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―A STUDY ON ASSESSMENT OF CHALLENGES AND EFFECTIVENESS 
OF INFECTION CONTROL MEASURES IN A TERTIARY CARE 
HOSPITAL USING SPECIFIC INFECTION CONTROL INDICATORS‖ 
 
INTRODUCTION 
 Health Care Associated Infections (HCAI) or infections acquired in health-care 
settings are a major public health problem for patient safety and its impact can result in 
prolonged hospital stay, long-term disability, increased resistance of microorganisms to 
antimicrobial agents, a massive additional financial burden for the health care system, high 
costs for patients and their families, and increased mortality.
1,2
 
 
 The hazard extends to the staff working in hospitals and also into the community at 
large. This has become more important in today's changing environment, dealing with the 
threats of newly emerging pathogens and the widespread dissemination of old pathogens.  
 
 The World Health Organization (WHO) Report on the burden of endemic HCAI 
worldwide, states that the incidence of Intensive Care Unit (ICU) acquired infection among 
adult patients in low and middle income countries ranged from 4.4% up to 88.9% 
3
. As per a 
systematic review, pooled overall HCAI density in adult ICU was 47.9 episodes per 1000 
patient-days which are at least three times as high as densities reported in developed 
countries.
2
 
 
 Among the HCAI, Urinary tract infections (UTI) are the most common, accounting 
for up to 40% of infections reported by acute care hospitals.
4,5
Also, 70 - 80% of UTI are 
associated with the presence of an indwelling urinary catheter.
6
 
 
 Antibiotic resistance in Gram-negative pathogens is a major global concern, 
bacterial resistance particularly in relation to Catheter-Associated Urinary Tract Infections 
(CAUTI) has major implications
7 
leading to increased hospital cost and increased 
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morbidity
8 
and mortality
5,9
. Up to 69% of CAUTIs are considered to be avoidable, provided 
that recommended infection-prevention practices are implemented.
10
 
 
 Surveillance of health-care-associated infections, defines the extent and nature of 
problem, which is the initial step toward reducing threat of infection in vulnerable 
hospitalized patients. Infection Control Committee (ICC), of any hospital, serves as a major 
tool for the surveillance of these infections. 
 
 Enough scientific evidence supports the observation that if properly implemented, 
hand hygiene alone can significantly reduce the risk of cross-transmission of infection in 
healthcare setting.
11,12 
Also presence of an active surveillance was associated with a 32% 
decrease in nosocomial infection rate, while absence of such a program was associated with 
an 18% increase in the nosocomial infection rate.
13
 Thus systematic surveillance is the most 
common activity of the Infection Control (IC) programme. 
 
 As infection control requires the ability to detect infections when they occur,the 
Clinical Microbiology laboratory is inextricably linked to any comprehensive IC 
programme.
14
 
 
 The role of Microbiology laboratory in infection control includes:Specimen 
collection, Antimicrobial Susceptibity Testing (AST) of HCAI pathogens, reporting 
laboratory data of organism requiring immediate notification, reviewing and analysing 
culture and AST which are important data source and  providing summary of antibiogram of 
HCAI pathogen. 
 
 Like in other developing countries, the priority given to prevention and control of 
HCAI is minimal in India. This is primarily due to lack of infrastructure, trained manpower, 
surveillance systems, poor sanitation, overcrowding and understaffing of hospitals, lack of 
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legislations mandating accreditation of hospitals and a general attitude of non-compliance 
amongst health care providers towards even basic procedures of infection control.
15
 
 
As per WHO fact sheet, the main solutions and perspectives for improvement are:
16 
 identifying local determinants of the HCAI burden; 
 improving reporting and surveillance systems at the institutional level, including 
Microbiology laboratories' capacity; 
 ensuring that core components for infection control are in place at the national and 
health-care setting levels; 
 implementing standard precautions, particularly best hand hygiene practices at the 
bedside; 
 improving staff education and accountability; 
 conducting research to adapt and validate surveillance protocols based on the reality 
of developing countries; 
 conducting research on the potential involvement of patients and their families in 
HCAI reporting and control. 
 
 Each year more is learnt about hospital infection control as a science, yet the human 
input is never as important as now to keep pace with the challenges of modern medicine and 
sophisticated therapeutic modalities many of which cause a significant increase in patient 
population susceptible to hospital infection. 
 
 The prevention, control and treatment of such infection is a concern of all health 
care professionals working in a hospital including microbiologists, clinical specialists from 
various disciplines of medicine and surgery, medical and nursing administrators. 
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 A periodical surveillance system for HCAI which is virtually non-existent in most 
low- and middle-income countries is essential to record the size of this infection burden and 
the effect of interventions. Moreover, many studies have stated that by itself, surveillance 
can lead to reduction in health-care-associated infection.
2,13,17
 
 
 The interrupted time series is the predominant study design for infectious disease 
epidemiology, especially in the hospital setting.
18
 
 
 With this background, this prospective interventional study was undertaken with the 
aim of assessment,intervention and evaluation of infection control measures in Intensive 
Medical Care Unit (IMCU) of a tertiary care hospital. 
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AIMS & OBJECTIVES 
 
AIMS 
 Assessment, Planning, implementation and evaluation of Infection control measures 
in IMCU of a tertiary care hospital using specific infection control indicators. 
 
OBJECTIVES 
 To determine the rate of infection control indicators viz Hand Hygiene Compliance 
(HHC), Catheter Associated Urinary Tract Infection (CAUTI), Prevalence of Multi 
Drug Resistant Organisms (MDROs) like Methicillin Resistant Staphylococcus 
aureus(MRSA) and Extended Spectrum Beta Lactamase (ESBL) in IMCU in the 
pre-intervention phase as the baseline evaluation. 
 To implement a comprehensive multimodal infection control programme as the 
intervention.  
 To re-evaluate the same infection control indicators in the post intervention phase. 
 To assess the challenges and effectiveness of infection control measures by 
statistically analyzing the rate of infection control indicators before and after the 
implementation of infection control measures. 
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REVIEW OF LITERATURE 
HCAI 
 Modern healthcare especially intensive care units, employs many types of invasive 
devices and procedures to treat patients and to help them recover. Also our knowledge and 
understanding of medical and Clinical Microbiology is constantly growing and expanding. 
The bacterial cell in the microbiota, (normal flora) outnumbers the human cells in the host 
by 10:1. In the hospital acute care IMCU settings, where vulnerable people are crowded 
together, the battle between man and microbe is at its most obvious. Patients are exposed to 
a variety of microorganisms during hospitalization and HCAI is the most frequent adverse 
event for hospitalized patientsand is a major global issue for patient‟s safety.It refers to 
infection associated with health care delivery in any setting. 
 
 Factors influencing the development of HCAI are severity of infection and 
existing illness, comorbid conditions, equipment and environment sanitation, practices and 
adherence to recommended guidelines. The more susceptible patients usually require the 
most intensive care with far more daily contacts with staffs who act as vectors in the 
transmission of microbes.Inanimate reservoir of infection, such as equipments, instruments 
and materials like fomites, linen used in hospitals often become contaminated with 
microorganisms which may subsequently transfer infection to susceptible patients. 
 
 Pathogenesis of infectious diseases depend on three main factors: the number and 
virulence of the microorganism, and the immune status of the host. The establishment of the 
infection is directly proportional to number and virulence characteristic of microbe and 
inversely proportional to immune status of the host.
19
 
 
 The infection may be of exogenous and endogenous. Endogenous are self-infection 
where the organisms are derived from patient‟s own skin, GI, upper respiratory flora. 
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Exogenous infections may be a cross infection when it is acquired from another patient or 
from HCP in the hospital or environmental infection when it is acquired through 
contaminated item from equipment or environment. 
 
Burden of HCAI 
 The frequency of IMCU-acquired infection in low- and middle-income countries is 
two to three times higher than in rich ones. HCAIs can double or quadruple the average 
length of hospital stay and jack up expenditure on drugs and diagnostics. Hospital staffs and 
all the health care providers are also at risk. The data available indicate that the burden of 
HCAI in low and middle income countries like India is high, with an estimated pooled 
prevalence of 15.5 per 100 patients, more than double the prevalence in Europe and the US 
20
 Infection prevention and control measures and practices reduce the opportunities for 
HCAI and multi drug resistant pathogens to spread in healthcare facilities. The burden of 
HCAI is also much more severe in high-risk populations such as adults housed in IMCUs 
and neonates, with general infection rates, particularly device-associated infection rates, 
several-fold higher than in developed countries. 
 
Types of health-care associated infection  
 HCAIs include central line-associated bloodstream infections (CLABSI), catheter-
associated urinary tract infections, and ventilator-associated pneumonia (VAP). Infections 
may also occur at surgery sites, known as surgical site infections. 
 
The dynamics of disease transmission
19
 
 Hospital constitutes a special environment where the epidemiology of infection is 
distinct. The chain of transmission of infection involves six vital links: the causative agent, 
reservoir of infection, portal of exit, mode of transmission, portal of entry and susceptible 
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host.Contact transmission is the most common mode. This may occur either as direct 
contact or indirect contact. 
 
Chain of transmission of infection 
 
 Patients constitute a special hazard as they are infectious and they may be unusually 
susceptible to infection due to their disease condition or treatment with broad spectrum 
antibiotics and with immunosuppressive agents. Special activities like invasive therapeutic 
procedure, surgery and extensive use of intravascular devices, life supporting devices also 
pose constant hazard. 
 
 The extensive use of broad spectrum antibiotics, disinfectants and need to reuse the 
equipments, contaminated environment contribute to the special environment. Certain 
MDRO like MRSA, ESBL, MDR Pseudomonas and Acinetobacter spp. are important 
agents of HCAI, can survive and persistent in the hospital environment and are difficult to 
eradicate. 
 
Risk factors of HCAI 
 There are patient, therapy and environment related risk factors for the development 
of HCAI. 
21
 
Patient related risk factors: 
 Age more than 70 years 
 Shock and Acute renal failure 
 Major trauma 
causative 
agent 
reservoir of 
infection 
portal of exit 
mode of 
transmission 
portal of 
entry  
susceptible 
host 
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 Coma -Therapy related risk factors 
 Prior antibiotics 
 Mechanical ventilation 
 Drugs affecting the immune system (steroids, chemotherapy) 
 Indwelling catheters - Environment related risk factors 
 Prolonged ICU stay (>3 days). 
 
Infection control and Surveillance of HCAI 
 Effective functioning of the infection control and prevention program is an essential 
part of the patient safety and quality improvement programme. The following are the five 
pillars of IC programme,
19
 
 
 Isolation of patient and use of personal protective equipments, 
 Hand hygiene, 
 Antibiotic policy, 
 Decontamination of equipments & Aseptic technique and  
 Environmental issues – cleaning and waste disposal 
 
 To monitor the effectiveness of IC practices, periodical surveillance and audits 
should be carried out.The fundamental aspect of IC and prevention is active search for 
disease among apparently healthy people. Surveillance has been defined as “the continuous 
scrutiny of all aspects of occurrence and spread of disease that are pertinent to effective 
control”. The ultimate objective of surveillance is prevention and to detect changes in the 
trend of occurrence of infection.It is therefore essential for effective control and prevention 
and includes collection,analysis,interpretation and distribution of relevant data for action.
22 
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 The hospital IC programme should include surveillance and prevention of HCAI, 
continuing education of HCPs, control of infectious diseases out break and protection of 
employees from infection and advice on new products and procedures.Surveillance allow 
the IC programme to monitor the frequency and type of HCAI, detect out breaks, evaluate 
compliance with IC guidelines, provide data for policy development and monitor the effect 
of IC intervention on HCAI rate. 
 
 Active HCAI surveillance are accounted with reduction in infection rate, the 
consequence, morbidity and mortality. Thus systematic s surveillance is the IC programme 
most common activity. 
 
 To accomplish the overall goal to reduce the infection rate the IC programme must 
provide surveillance data to clinicians as soon as possible; accompanied by suggestions for 
improvement and reminders of existing IC practices. 
 
 As surveillance is resources intensive and time consuming, an effective IC 
programme must decide on the most efficient surveillance system possible. Various other 
screening technique too increases surveillance effect. This include, use of Microbiology 
report, nursing care plans, antibiotic orders, radiology reports, vital science and discharge 
summary. Most complete and effective surveillance system requires infection control 
personnel to review case sheet of all hospital patients daily. In lab based surveillance, 
review of microbiology report is being done to screen large amount of data. The sensitivity 
and specificity of laboratory based surveillance depends on nature of the quality of 
specimen and the frequency which were culture done. An optimal surveillance should 
include data from more than one source. 
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 Process surveillance: The importance of adhering to safest process (Ex HHC, 
adopting bundle care) can be established by process surveillance. It can help IC personnel to 
understand the some of the variables in HCAI rate, may improve practices and HCAI rate
14
. 
 
Standardized definitions of HCAI 
 CDC has provided the definition of HCAI (CDC definition of health-care associated 
infection 2015). The standardized definition helps to decrease subjectivity, improve patient 
care and optimizes the data consistency. 
 
 An Infection is considered as HCAI, when the date of event occurs on or after the 
3rd calendar day of admission. The date of Event (DOE) is the first element used to meet 
National Healthcare Safety Network (NHSN) site specific infection criterion, occurs for the 
first time within the seven- day infection window period.  
 
 National Healthcare Safety Network is the most widely used HCAI tracking system 
of CDC. NHSN provides facilities wise, regions wise and the nation wise data needed to 
identify problem areas. It also helps to measure progress of prevention efforts, and 
ultimately eliminate HCAI.
23
Such international data cannot be generalized, as each hospital 
has its own risk factors that can influence the rates of HCAI. 
 
 Infection Window period is defined as the 7- days during which all site- specific 
infection criteria is met. It includes the date of first positive Diagnostic test, 3 calendar days 
before and the 3 calendar days after the positive Diagnostic test. 
 
 Repeat infection time frame (RIT)-is a 14 – day timeframe during which no new 
infections of the same type are reported. It reduces labour of surveillance. If the potential 
next event is within 14 days of DOE of the previous one, then no need to report the new 
event and additional pathogens identified are added to the original event. 
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 Secondary BSI attribution period: This period includes the infection window period 
combined with RIT (depending upon the date of event). Within this period a positive blood 
culture must be considered as a secondary BSI to primary site infection. 
 
Infection control-Indian scenario 
 Definite guidelines and policies for appropriate use of antimicrobial for specific 
national health programmes like RNTCP, National AIDS control programme, National 
vector borne control programme were available at national level for many years. For other 
disease and pathogens of public health importance and infection control program such 
policies were not available. 
 
 Guidelines on Prevention and Control of Hospital Associated Infections was 
published by World Health OrganizationRegional Office for South-East Asia, New Delhi on 
January 2002. These guidelines included organization of the infection control programme, 
management of hospital environment, care of high-risk areas and patients, surveillance and 
outbreak investigation, isolation procedures, standard precautions as well as care of hospital 
staff.
24 
 
 Publications from India on prevention of infection and control are only a few and on 
antibiotic stewardship are even fewer (Table) 
25 
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 The Indian Council of Medical Research (ICMR) in its centenary year 2011-2012 
planned workshops in thrust areas such as that of antibiotic use,resistance and infection 
control. This area is unique as it is truly an integrated area covering the disciplines of 
clinical pharmacology, microbiology and infectious disease. 
 
 Under the Antibiotic Stewardship, Prevention of Infection and Control (ASPIC) 
programme of ICMR 15 microbiologists, four pharmacologists and one physician were 
trained in 2012.The trained participants from 20 centres across India were expected to start 
antibiotic stewardship and infection control and ultimately contain antimicrobial resistance 
in their respective centres.National antibiotic policy or a national policy to contain 
antimicrobial resistance in India published in 2011 has been put on hold due to non-
implement ability of major recommendations.
26 
 
 Medical societies in India came together and organised a symposium - A Roadmap 
to Tackle the Challenges of Antimicrobial Resistance - in Chennai on August 24, 2012 to 
discuss the growing problem of antimicrobial resistance and its possible solutions.The 
Chennai Declaration calls for urgent initiatives to formulate an effective national policy to 
control the rising antimicrobial resistance, including a ban on over-the-counter sale of 
antibiotics, and to bring about changes in the medical education curriculum to include 
training in antibiotic usage and infection control. 
 
 The Indian Council of Medical Research (ICMR), New Delhi, India, has launched 
the Anti Microbial Resistance Surveillance and Research Network (AMRSN) across the 
country in 2013 with an avowed purpose of rationalizing AMSP in India. Treatment 
guidelines for important clinical infections and hospital infection control (HIC) guidelines 
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were prepared.This initiative was in line with the recommendations of Chennai Declaration 
which coincided with the global initiatives to combat AMR.
27 
 
 Experts from various medical science came together and prepared the National 
Antimicrobial use guidelines for infectious diseases. ―National antibiotics guideline‖ released 
by Indian Ministry of Health. Union health minister of India released the document during 
International conference on AMR, New Delhi, organised by MOH and WHO, in Feb 
2016.
28  
 
 Although hospital accreditation is not mandatory in India, groups like the 
autonomous National Accreditation Board of Hospitals and the National Health Mission‟s 
National Health Systems Resource Centre have incorporated programmes on infection 
prevention and control, including surveillance of HCAI, as a core part of the certification 
process.29,30 At the national level, there has been growing recognition of the need for policy 
and guidance documents, and in 2016 the ICMR released guidelines on infection prevention 
and control.
31
 In addition, as part of the national Swacch Bharat Abhiyan (clean India 
mission) the National Health Mission launched Kayakalp (clean hospital initiative), which 
aims to promote and reward cleanliness, hygiene, and infection control practices in public 
healthcare facilities.
32 
 
Standard Precautions 
 Standard Precautions are the minimum infection prevention practices that apply to 
all patient care, regardless of infection status of the patient, in any healthcare setting. These 
practices are designed to protect both healthcare personnel (HCPs) and prevent HCPs from 
spreading infections among patients, especially those due to blood-borne pathogens.  
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 In August 1987, CDC initially introduced the concept of Universal Precautions, 
stating blood and certain body fluids of all patients are considered potentially infectious for 
HIV, hepatitis B virus (HBV) and other bloodborne pathogens, regardless of their 
bloodborne infection status. Thus, Universal Precautions should apply to all patients. 
 
 The relevance of Universal Precautions applied to other potentially infectious 
materials was recognized later, and in 1996, CDC replaced Universal Precautions 
with Standard Precautions.  
 
 Standard Precautions integrate and expand Universal Precautions to include 
organisms spread by blood, all body fluids, secretions, and excretions except sweat, 
regardless of whether they contain blood;Non-intact skin and mucous membranes. 
 
These Standard Precautions include: 
1) Hand hygiene,  
2) Use of PPE such as gloves, masks, eye protection, and gowns, that are intended to 
prevent the exposure of skin and mucous membranes to blood and other potentially 
infectious materials. 
3) Injury prevention through safe injection practices and safe handling of sharps 
4) Proper cleaning and decontamination of patient care equipment. 
5) Cleaning and disinfection of environmental surfaces. 
6) Sterilization 
7) Disinfection 
8) Proper Biomedical waste management 
9) Adherence to correct hospital sterilization disinfection protocols 
10) HBV immunization of HCP at risk. 
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Normal Bacterial Skin Flora 
 The superficial part of the skin, the epidermis, has the stratum corneum, as the 
outermost layer, and is composed of flattened dead cells. From healthy skin, approximately 
10
7
 particles are disseminated into the air each day, and 10% of these dead cells contain 
viable bacteria.  
 
 Normal human skin is colonized with bacteria; different areas of the body have 
varied bacterial flora and variable bacterial counts. Total bacterial counts on the hands of 
medical personnel have ranged from 3.9 × 10 
4
 to 4.6 × 10 
6
. Bacteria recovered from the 
hands are divided into two categories: transient flora and resident flora.
33 
 
 Transient flora, which colonize the superficial layers of the skin. They are often 
acquired by HCPs during direct contact with patients or contact with contaminated 
environmental surfaces. Transient flora are the organisms most frequently associated with 
healthcare associated and laboratory associated infections and it can be removed by hand 
hygiene practices. 
 
 Resident flora, which are attached to deeper layers of the skin, are more resistant to 
removal. In addition, resident flora (e.g., coagulase-negative staphylococci and 
diphtheroids) are less likely to be associated with such infections.  
 
Hand Hygiene 
 Hand washing remain the simplest and most effective methods of preventing 
transmission of infectious agents from clinicians to patients and among patients. Several 
hospital-based studies demonstrated that improved hand hygiene techniques significantly 
reduced infection rates. 
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 Hand hygiene is an important indicator of safety and quality of care delivered in any 
health-care setting is emphasized in the WHO Collaborating Centre on Patient Safety 
Solutions. 
34 
 
 An alcohol handrub, correctly applied to socially clean hands is an acceptable and 
very effective method of hand decontamination and is now the preferred method of hygienic 
hand hygiene in most clinical situations. Alcohols effectively reduce bacterial counts on the 
hands. Typically, log reductions of the release of test bacteria from artificially contaminated 
hands average 3.5 log10 after a 30-second application and 4.0–5.0 log10 after a 1-minute 
application.
35 
 
 
 Health-care–associated pathogens can be recovered not only from infected or 
draining wounds, but also from frequently colonized areas of normal, intact patient skin. 
Many studies have documented and proved evidence based the contamination of HCPs 
hands with potential health-care–associated pathogens. 
 
Events of Transmission of Pathogens on Hands 
 Transmission of health-care–associated pathogens from one patient to another via 
the hands of HCPs requires the following sequence of events:  
Organisms present on the patient‟s skin        Organisms shed onto inanimate objects 
 
 
transferred to the hands of HCWs. 
(survive for several minutes on the hands) 
 
 
Inadequate, inappropriate or omitted hand washing 
& 
poor adherence to hand-hygiene policies 
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contaminated hands 
 
 
             direct contact with another patient               with an inanimate object 
 
 
Transmission of health-care–associated pathogens 
 
 Outbreak investigations have indicated an association between infections and 
understaffing or overcrowding; the association was consistently linked with poor adherence 
to hand hygiene. During an outbreak investigation of risk factors for CLABSI,
36
 after 
adjustment for confounding factors, the patient-to-nurse ratio remained an independent risk 
factor for bloodstream infection, indicating that nursing staff reduction below a critical 
threshold may have contributed to this outbreak by jeopardizing adequate catheter care. The 
understaffing of nurses can facilitate the spread of MRSA in intensive-care settings 
37
 
through relaxed attention to basic control measures (e.g., hand hygiene). 
 
Hand hygiene technique 
 Amount of hand-hygiene solution and duration of hand-hygiene procedure should be 
as per Manufacturer‟s instructions. Dispense the required amount of alcohol handrub and 
vigorously rub hands together for 15 - 30 seconds until dry, ensuring that all areas of the 
hands and wrists are covered as per the WHO “How to hand rub” process. Alcohol 
handrubs are only effective when used on socially clean hands and when allowed to dry.  
 
Hand washing 
 A hand wash using aliquid soap may be used as an alternative to the above 
method.Soap and water are recommended for visibly soil hands.Rub hands together 
applying the soap for at least 30 – 40 seconds, covering all surfaces, focussing on fingertips 
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and fingernails.Rinse under running water and dry with disposable towel. Hand drying is an 
essential part of hand hygiene.Use towel to turn off the faucet 
 
Steps of hand hygiene - WHO recommends steps given in Figure 1. 
1. Rub palm to palm 
2. Right palm over left dorsum and left palm over right dorsum 
3. Palm to palm finger interlaced 
4. Backs of fingers to opposing palms with fingers interlocked  
5. Rotational rubbing of rights thumb clasped in left palm and vice versa 
6. Rotational rubbing back and forwards with clasped fingers of right hand in left palm 
and vice versa 
7. Rub both wrists in a rotating manner. Rinse and dry thoroughly. 
 
Fig 1 : How to hand wash? - WHO recommended steps. 
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WHO recommends alcohol-based hand rubs based on the following factors: 
1. Evidence-based, intrinsic advantages of fast-acting and broad-spectrum microbicidal 
activity  (excellent in vitro germicidal activity against gram-positive and gram-
negative vegetative bacteria, including multidrug-resistant pathogens (e.g., MRSA 
and VRE),Mycobacterium tuberculosis,various fungiandenveloped lipophilic viruses 
(e.g., herpes simplex virus, HIV, influenza virus, respiratory syncytial virus, and 
vaccinia virus) with a minimal risk of generating resistance to antimicrobial agents; 
2. Suitability for use in resource-limited or remote areas with lack of accessibility to 
sinks or other facilities for hand hygiene (including clean water, towels, etc.); 
3. Capacity to promote improved compliance with hand hygiene by making the process 
faster and more convenient; 
4. Economic benefit by reducing annual costs for hand hygiene,  
5. Minimization of risks from adverse events because of increased safety associated 
with better acceptability and tolerance than other products 
 
Limitations of alcohol-based hand rubs: 
1. Alcohols are rapidly germicidal when applied to the skin,but without appreciable 
residual activity. Addition of chlorhexidine, quaternary ammonium compounds, 
octenidine, or triclosan to alcohol-based solutions can result in persistent activity 
35 
2. As HCPs may wash their hands from a limited number of times to as many as 30 
times per shift, the tendency of products to cause skin irritation and dryness is a 
substantial factor that influences acceptance, and ultimate usage.
38  
3. The drying effects of alcohol was a primary cause of poor acceptance of alcohol-
based hand-hygiene products. However, several studies havedemonstrated that 
alcohol-based hand rubs containing emollients are acceptable to HCPs. 
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4. With alcohol-based products, the time required for drying may also affect product 
acceptance. 
 
 Product-selection committees must consider factors that can affect the 
overallefficacy of such products, including the relative efficacy ofantiseptic agents against 
various pathogens. In addition to evaluating the efficacy and acceptability ofhand-care 
products, it shouldinquire about the potential deleterious effects that oilcontaining products 
may have on the integrity of rubber gloves. Characteristics of a HH product, either soap or 
alcohol-based hand rub that canaffect acceptance by personnel, include its smell, 
consistency or “feel”, and color. For soaps, ease of lathering also may affect user 
preference. 
39 
 
 
 The vital component of any successful IC programme is evaluation and repeated 
monitoring of IC practices and HCPs knowledge and perception of the problem of HCAI 
and the importance of hand hygiene. 
 
Monitoring hand hygiene compliance is of crucial importance to: 
 assess baseline compliance by HCPs 
 provide feedback to health-care workers about defective practices as well as 
improvement, 
 evaluate the impact of promotion interventions, and 
 Investigate outbreaks. 
 Unobtrusive direct observation of hand hygiene practices by a trained observer is 
considered the gold standard for evaluating compliance. Detailed instructions on this 
method are included in the Hand Hygiene Technical Reference Manual.
40
The 
advantage of this method is, it directly links the indication of HH with the 
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performance of the act and the disadvantage is potential observer bias and Hawthorn 
effect. 
 The WHO observation form exists for both hospitals and outpatient care settings.  
 Web-based data collection and entry applications using touch screen and mobile 
devices have been developed and are being used in a number of countries. (Hand 
Hygiene Australia – HHCApp) 
 Innovative electronic systems for the automatic monitoring of HHC are now 
available and can significantly facilitate data collection. 
 Conducting surveys on HCPs perception, attitude and behavior of theirs and other 
HCP on HH. Survey of self-reporting is unreliable. A well designed and carefully 
administered survey can help in achieving reliable and accurate results. 
 Consumption of HH products, in particular alcohol-based handrub, is another useful 
indicator. Data can be calculated easily at any place or at any time and can be 
correlated with infection trends over time.The disadvantage is, it does not provide 
any contextual information of non-compliance or product spillage or pilferage. 
 Unfortunately there is no single perfect method for monitoring the HHC, each 
method has its own limitations. Collecting reliable data requires highly structured 
procedure of observation and documentation of data. Using multiple measurement 
approach helps in confirming the findings and it gives reliable information on HHC 
than any single method. 
 
Intervention to improve the HHC: 
 Hand-hygiene promotion has been challenging for more than a century. It involves 
factors at both the individual and system level. The dynamic of behavioural change is 
complex and involves a combination of education, motivation, and system change. 
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 Education is the cornerstone for improvement with HH practices.  
 Motivation, or system change. 
 Routine observation and feedback,  
 alcohol hand rub made available,convenient sink locations 
 Signs, verbal reminders to physicians, movies, posters, and brochures,  
 dissemination of literature, and results ofenvironmental cultures,  
 Performance feedback, policy reviews,  
 individual reinforcement technique, appropriate rewarding, administrative sanction, 
memo, and  
 administrative support 
 
 Several investigators reported improved adherence afterimplementing various 
interventions, but the majority of studies had short follow-up periods and did not confirm 
whetherbehavioral improvements were long-lasting. Other studiesestablished that sustained 
improvements in hand washing behavior occurred during a long-term program to 
improveadherence to HH policies. Organisational characteristics, such as leadership, 
convenient placement of HH products, remainders and staff workload play a big influence 
on HHC. Strong system to support, monitor and guide is necessary to integrate the HH into 
the routine practice. Ultimately, adherence to recommended hand-hygiene practices should 
become part of a culture of patientsafety. 
 
CAUTI 
 A urinary tract infection (UTI) is an infection involving any part of the urinary 
system, including urethra, bladder, ureters, and kidney. UTIs are the most common type of 
HCAI reported to the NHSN.
41 
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Standard case definition of CAUTI
42
  
 Patient who has an indwelling urinary catheter in place > 2 calendar days and 
catheter still present on the date of event or removed the day before the date of event. 
 
At least 1 of following: Fever > 38 °C, suprapubic tenderness, Costovertebral angle pain 
or tenderness, urinary urgency, urinary frequency, dysuria 
 
                    Urine culture ≥ 105 CFU/ ml with no more than 2 species 
 
 CAUTI is also considered when urine showed pyuria (>10 leukocytes /mL of urine) 
or > three WBC / high power field in centrifuged organisms seen on Gram stain. 
 
Risk factors for CAUTI 
 Among UTIs acquired in the hospital, approximately 75% are associated with a 
urinary catheter and Infection is the most important adverse outcome of urinary catheter 
use.
43 
 
 Between 15-25% of hospitalized patients receive urinary catheters during their 
hospital stay.  The most important risk factor for developing a catheter-associated UTI 
(CAUTI) is prolonged use of the urinary catheter.  Therefore, catheters should only be used 
for appropriate indications and should be removed as soon as they are no longer needed. 
44 
 
 Other risk factors are female, older age, Diabetes mellitus, Malnutrition failure to 
use closed drainage system and failure to adhere aseptic technique during insertion and 
maintenance. 
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Background—Strategies to Prevent CAUTI 
 Guidelines incorporating various simple methods and strategies to control HCAI 
have been published regularly by the CDC and the World Health Organization. 
 
 The CDC published guidelines for prevention of CAUTI in 1981, and these were 
updated in 2009.
45 
These guidelines provide recommendations for catheter use, 
catheter insertion, catheter care, and implementation of programs to prevent CAUTI. 
 The IDSA, together with other professional societies, published international 
guidelines for the management of CAUTI in 2010.
46
 
 In the document, “Strategies to Prevent Catheter-Associated Urinary Tract 
Infections in Acute Care Hospitals; 2014 update” the guidelines published in 2008 
was updated. This expert guidance document is sponsored by the Society for 
Healthcare Epidemiology of America (SHEA). 
47
 
 
 A systematic review in hospitalized patients reported that the use of an intervention 
including a reminder to staff that a catheter was in place and/or a stop order to prompt 
removal of unnecessary catheters reduced the CAUTI rate by 53%.
48 
 
 A care bundle identifies a set of key interventions from evidence-based guidelines 
that, when implemented together, are found to be more effective than the sum of its parts.
49 
 
Recommendation for Surveillance 
 The CDC/HICPAC system for categorizing recommendations is as follows: each 
recommendation is categorized on the basis of existing scientific data, theoretical rationale, 
applicability, and economic impact 
 
Category IA - Strongly recommended for implementation and strongly supported by well-
designed experimental, clinical, or epidemiologic studies.  
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Category IB - Strongly recommended for implementation and supported by certain 
experimental, clinical, or epidemiologic studies and a strong theoretical rationale.  
 
Category IC - Required for implementation, as mandated by federal or state regulation or 
standard. 
 
Category II - Suggested for implementation and supported by suggestive clinical or 
epidemiologic studies or a theoretical rationale.  
 
No recommendation - Unresolved issue. Practices for which insufficient evidence or no 
consensus regarding efficacy exist. 
 
Standardized methodology for performing CAUTI surveillance – 
There is a level 1 B evidence.  
1. Examples of metrics that should be used for CAUTI surveillance include:50 
a. Number of CAUTI per 1000 catheter-days 
b. Number of bloodstream infections secondary to CAUTI per 1000 catheter-days 
c. Catheter utilization ratio: (urinary catheter days/patient days) × 100 
2. Use CDC/NHSN criteria for identifying patients who have symptomatic UTI (SUTI) 
(numerator data) 
51 
3. Routine screening of catheterized patients for asymptomatic bacteriuria (ASB) is not 
recommended.
 
 
Anti-Microbial resistance (AMR) 
 AMR poses a profound threat to human health and also it threatens the very core of 
modern medicine and the sustainability of an effective, global public health response to the 
enduring threat from infectious diseases.  
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 One of the main objective to deal with the crisis of AMR is to strengthen the 
knowledge and evidence base through surveillance and research. Better hygiene and 
infection prevention measures are essential to limit the development and spread of 
antimicrobial-resistant infections and multidrug-resistant bacteria. 
52
 
 
 Information on: the incidence, prevalence, range across pathogens and geographical 
patterns related to antimicrobial resistance is needed to be made accessible in a timely 
manner in order to guide the treatment of patients; to inform local, national and regional 
actions; and to monitor the effectiveness of interventions and no single or simple strategy 
will suffice to fully contain the emergence and spread of infectious organisms. 
 
Multi-drug resistant organisms:   
 (MDRO) are those organisms which are resistant to at least one agent in at least 
three antimicrobial classes of Cephalosporins, β-lactam/β-lactamase inhibitors, 
Carbapenems, Fluoroquinolones, Aminoglycosides
39 
 
Extensive Drug Resistant(XDR):  
The isolates will be resistant to carbapenems in addition to the MDR drugs. 
 
Pan Drug Resistant(PDR): 
 The isolated will be resistant to all the available drugs,includingpolymyxins and 
tigecycline. 
 
The acquisition and spread of antibiotic resistance in bacteria: 
Inherent (natural) resistance:In which bacteria may be inherently resistant to an 
antibiotic, which is reflected in wild type antimicrobial patterns of all or almost all 
representatives of a species. Pseudomonas aeruginosais intrinsically resistant to 
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amoxicillin, ampicillin, ampicillin-sulbactam, amoxicillin-clavulanate, cefotaxime, 
ceftriaxone, ertapenem, trimethoprim-sulfamethoxazole, tetracycline, and chloramphenicol. 
 
Acquired resistance: may be due tomodification of existing genetic material (chromosomal 
mediated) or due to theacquisition of new genetic material from another source (plasmid 
mediated) 
35
. Plasmid mediated resistance is usually based on the production of enzymes or 
change in the target protein. Plasmid mediated resistance is of great clinical importance than 
the chromosomal mediated resistance as it can be transferred from one bacterium to another.  
The reason for the acquired resistance may be  
 Over use and misuse of an antibiotic and is the most common cause.Evolution of 
strains among bacteria, is a natural phenomenon, which can occur when an antibiotic 
is over used. 
 Use of particular antibiotic continuously, poses selective pressure in a population of 
bacteria which promotes resistant bacteria to thrive and the susceptible bacteria to 
die off. 
 Extrinsic mechanisms include acquisition of resistance genes such as extended 
spectrum beta-lactamases and carbapenemases. 
 
 Various mechanisms for MDR include loss of outer membrane protein, over 
expression of efflux pump (e.g. tetracycline), modification of cell wall protein, production 
of β-lactam hydrolyzing enzymes such as extended spectrum β-lactamases (ESBL) 
&AmpCβ-lactamases and carbapenemhydrolyzing enzymes (metallo-β-lactamases, 
oxacillinase). 
53 
 
 The emergence and rapid spread of Multidrug resistant isolates causing HCAI are of 
great concern worldwide. It poses complex problem to the treating clinician and adversely 
affects the clinical outcome of the patients.Hence identification of invitro antimicrobial 
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susceptibility pattern and special resistance pattern is important before treating infections 
with MDRO. 
 
 For ESBL and AmpC producers, Carbapenems remain the drug of choice, however 
resistance to these drugs is also on the rise.To treat carbapenem resistant strains we are left 
with tigecycline and polymyxin B and polymyxin E (Colistin) to which many Gram 
negative bacteria have started developing resistance. Hence the detection of Carbapenem 
resistance is important in treatment of patients and also preventing the spread of resistant 
strains. 
 
 K. pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp. are top of the list 
of pathogens causing IMCU infections. Itmay spread remarkably well in the hospital 
environment, and frequently cause HCAI and outbreaks, especially in IMCUs. Medical 
equipment, the gastrointestinal tract of patients and the hands of HCPs are considered the 
most important reservoirs for the spread of Klebsiella species in the hospital environment. 
 
Mechanisms of β-lactam resistance: 
 Resistance to β-lactams may be either due to alteration of the target site, (Penicillin 
Binding Protein-PBP mediated), or caused by production of β-lactamases.  Down-regulation 
orporin loss may cause β-lactam resistance alone, or in combination with β-lactamase 
production. PBP-mediated resistance may be caused by acquisition of foreign PBPs, e.g. 
acquisition of the gene encoding PBP2a in methicillin resistant Staphylococcus aureus 
(MRSA). 
 
 Destruction or inactivation of β-lactam antibiotics by hydrolysing the amide bond of 
the β-lactam ring by the enzyme β-lactamase is the most common mechanism of β-lactam 
resistance among Gram-negative bacteria. They may be classified based on their primary 
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structure according to Ambler R36, or due to their functional characteristics (i.e. the 
enzymes abilities to hydrolyse different β-lactam classes) according to Bush-Jacoby-
Medeiros.
54
ESBL belongs to Class A beta-lactamase of Ambler molecular classification 
while AmpC beta-lactamase belongs to Class C. 
 
 β-lactamase enzymes hydrolyse penicillin, aztreonam and cephalosporins but not 
cephamycin (cefoxitin) or carbapenems. In Amp C related resistance, in contrast to ESBLs 
they hydrolyse Cefoxitin and coxyimino-cephalosporins except fourth generation 
cephalosporins. Carbapenems, β-lactams and β-lactam inhibitor combinations such as 
piperacillin-tazobactam are the drugs active against ESBL and AmpC producers. 
 
 Carbapenem resistance enzymes belong to Class B β-lactamase of Ambler 
classification. These enzymes can hydrolyse all classes of β-lactam antibiotics with the 
exception of monobactams (Aztreonam) and resist neutralization by β-lactamases inhibitor 
antibiotics. However, for isolates that also co-produce AmpC or ESBL, aztreonam is 
ineffective. 
 
Risk factors for the MDROs 
 Use of broad spectrum antibiotics (second & third generation cephalasporins and 
quinolones), treatment with previous glycopeptide in VRE patient. 
 chronically debilitated patients with severe underlying illness. 
 immunocompromisedpatients,critically ill patients with prolonged hospital stay in 
ICU, oncology and transplantation ward 
 Patients with indwelling devices, 
 Patients who had intra-abdomonal, cardiothoracic, orthopedic, vascular procedure 
and surgery  
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 Contact with health care facility (> 12 continuous hours in the past 12 months) 
where MDRO is endemic. 
 
Recommended measures to control spread of MDRO: 
i) Improved laboratory detection and reporting of MDRO  
ii) Enhanced infection surveillance and control in IMCUs  
iii) Isolation of patients and prevent spread by barrier precautions: Gowns and gloves  
iv) Hand Washing  
v) Cleaning and decontamination of patient care equipments and environment. 
vi) Implementation of ASP and restricted use of 3rd generation cephalosporins 
vii) Education and training 
 
Role of Microbiology laboratory
19
 
 The Microbiology laboratory must use internationally accepted methods for prompt 
and accurate identification and AST of HCAI pathogens. 
 Keep updated in the detection methods of resistance in MDROs. 
 Microbiology laboratory must follow restricted reporting based on the local 
guidelines to encourage the use of narrow spectrum antibiotics. 
 Establish local laboratory surveillance system and feed data into national 
surveillance system. 
 Surveillance of MDROs with the help of HIC team to monitor the epidemiological 
trend 
 To help the hospital administration to develop Antibiotic guidelines based on the 
local antibiotic resistance pattern. 
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METHODOLOGY 
 
PATIENTS AND METHODS 
Study design   - Prospective interventional study 
Study period  - 3 years 
 
Plan of study 
First year   -  July 2015 – March 2016 
 Extensive review of literature was done.  
 Methodology was standardized 
 Research proposal was presented to University Scientific committee 
 FGD facilitation guide, KAP questionnaire prepared and pilot testing was done  
 
Second year  
 Base line evaluation - April 2016 to September 2016. 
 Intervention - October 2016 to January 2017 
 Post interventional evaluation - February 2017 to July 2017 
 
Third year  (August 2017- July 2018) 
 Compilation and tabulation of study findings, 
 Statistical analysis of the results, 
 Synopsis of the study prepared and submitted. 
 
Place of study 
 Institute of Microbiology and Intensive Medical Care Unit of Rajiv Gandhi 
Government General Hospital, Madras Medical College, Chennai. 
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Ethical consideration 
 The study was approved by the Institutional Ethics Committee of Madras Medical 
College and an informed written consent (Annexure i) was obtained from the participants 
before the collection of the samples and before their participation in questionnaire survey, 
and Assent was obtained from those below 18 years of age. 
 
Statistical analysis 
 Categorical data were presented as proportions. Normally distributed continuous 
data were presented as mean with standard deviation. Non-normally distributed continuous 
data were presented as median with interquartile range. Data were descriptively analyzed 
using the Statistical Package for the Social Sciences 16.0 (SPSS). Chi square test was used 
to analyze the strength of association of duration of catheterization and the risk of 
developing CAUTI. In the post interventional, Knowledge Attitude and Practice (KAP) 
questionnaire study, mean was calculated for the parameters. Comparison of knowledge to 
attitude, knowledge to practice and attitude to practice was done by Independent sample t 
test. p value < 0.05 was considered as significant. 
 
Study population 
 Doctors and other Health Care Personnel (HCP) serving in the IMCU.Patients who 
got admitted in IMCU. 
 
Inclusion criteria 
 Doctors and other HCP serving in the IMCU. 
 Patients who got admitted and stayed in the IMCU for ≥48 h, were followed 
prospectively. 
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Exclusion criteria 
 Patients discharged, expired or transferred out from IMCU in < 48 h, 
 Patient with symptoms of UTI prior to the catheterization and on suprapubic and 
condom drainage were excluded. 
 Patients undergoing cancer chemotherapy and patients who have undergone bone 
marrow and solid organ transplantation were excluded from the study. 
 
Operational definition 
Hand Hygiene (HH) - A general term referring to any action of hand cleansing. Hand 
rubbing with an alcohol-based hand rub or hand washing with soap and water aimed at 
reducing or inhibiting the growth of micro-organisms on hands.
55 
 
Hand Hygiene Compliance (HHC) - Compliance with hand hygiene is the ratio of the 
number of performed actions to the number of opportunities. This reflects the degree of 
compliance by HCP with the requirement to practise hand hygiene during health-care 
activities in line with the five indications (moments) insofar as they are counted as 
opportunities.
55 
 
Catheter associated urinary tract infection - A patient was said to be suffering from 
catheter-associated urinary tract infection (CAUTI) if he was catheterized and he developed 
one or more of the following condition that is fever (temp > 38°C) without any other known 
cause, urgency, frequency, dysuria or suprapubic tenderness with urine culture showing 
more than 10
5
 colony-forming units or more per ml of urine, with not more than two types 
of organism. 
56 
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Multi drug resistance organisms (MDRO) 
 MDR bacteria is defined as non-susceptibility to one or more antimicrobials of three 
or more Antimicrobial classes.
57
 
 
Sample size- Sample size was 200 per group. 
 
Sample size calculation was done using the below formula. 
•  Sample size is 200 per group. n  = [P1 (100-P1) + P2 ((100 – P2)]   (Z+ Z)
2
 
             (P1-P2)
 2
 
Anticipated values of the population proportions = P1 & P2 
Level of Significance     = 100 (1-) %  
Power of the Test     = 100 (1-) % 
Medically Meaningful Difference   = d 
 
Data collection 
 Demographic details and other relevant details was collected using standard 
proforma (Annexure ii) by the investigator. 
 
Methodology - Prospective interventional study plan 
 
Base line or pre interventional phase 
 To achieve the objectives, in the beginning of the study as Base line or Pre-
interventional  evaluation of the infection control indicators such as HHC, CAUTI rate and 
MDRO rate was calculated for a period of six months from April 2016 to September 2016. 
 
Sampling procedure 
 For calculation of CAUTI rate,urine samples from all the consecutive patients 
fulfilling the inclusion criteria were included. 
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 For calculation of MDRO rates all the consecutive clinical samples such as blood, 
urine, tracheal aspirate, sputum, pus and other body fluids collected from symptomatic 
IMCU patients were included during the study period. 
 
Microbiological methods of processing the samples was done as per the standard 
procedure .
58,59 
This included, 
1. Collection of specimen 
2. Macroscopic examination  
3. Microscopic examination 
4. Culture procedure 
5. Identification of organisms 
6. Antibiogram- antibiotic susceptibility testing  
7. Test for detection of special resistant patterns: MRSA, ESBL and 
Carbapenemase production 
 
Collection of Specimens: Blood 
 After choosing the venepuncture site the skin was disinfected first with 70% alcohol 
in circular motion. Allowed to air dry. Then 2% povidone iodine was applied and allowed 
to dry for one minute 
 
 After disinfecting the venepuncture site about 10 mL of venous blood was drawn 
from 2 different sites using sterile disposable needle and syringe and inoculated into 50 mL 
of Brain Heart Infusion (BHI) broth. 
 
Urine 
 Clean catch midstream urine collected in a sterile, wide mouthed, screw capped 
bottle after thorough preliminary cleaning of external genitalia with soap and water. 
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 In catheterized patient, after disinfecting a portion of the catheter tubing with 
alcohol, urine sample was collected by puncturing the tubing with sterile syringe and 
needle. 
 
Sputum 
 Patients were instructed to have mouth wash and gargle with sterile distilled water 
and to cough when the sputum is felt in the throat and to spit the material directly in to a 
wide mouthed sterile container.  
 
Tracheal Aspirate (TA) 
 The collection of TA by the traditional technique was performed according to 
standard procedure. The sterile suction tube introduced through the ETT until resistance 
was encountered (level of the carina in the trachea), and retracted approximately 2cm. This 
was followed by the release of the vacuum and the suction tube was delicately removed 
using turning movements, from which the secretion was aspirated into a sterile culture tube 
or the distal end of the tube was cut and send for the culture under aseptic precaution.
60 
 
Body Fluids - Pleural   fluid, Ascitic fluid, Cerebro Spinal Fluid (CSF) 
 Collected by aspiration with a needle and syringe under aseptic precaution by 
trained physician. 
 
Macroscopic Examination Sputum 
 Sputum was examined for color and consistency and presence of mucus, 
mucopurulent and frothy material. Urine and other body fluids were examined for color, 
consistency, turbidity and presence of blood. 
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Initial processing of the specimen 
 All body fluid specimens greater than one mL in volume was subjected to 
centrifugation for 15 minute at 1500 g. Supernatant was transferred to a sterile tube, leaving 
approximately 0.5 mL of fluid to suspend the sediment before smear examination or culture.  
 
Microscopic Examination  
Gram Stain 
 Smears  from sputum, pus and other body fluids were stained by Gram„s method and 
examined for the presence of squamous epithelial cells, polymorphonuclear leukocytes, 
mononuclear leukocytes, Gram positive, Gram negative bacteria and Yeast cells.  
 
Culture procedure to isolate and identify bacteria:  
Blood sample 
 10 mL of blood from 2 sites was inoculated into 50mL of BHI broth and incubated 
at 37
o
C. Sub cultures were made at 24 hrs, 48 hrs and 5 days and on 7
th
 day onto Mac 
Conkey (MAC), Blood agar plate (BAP) and Nutrient agar (NA) plate incubated 
aerobically. Blood agar plate was incubated in candle jar. 
 
Urine Sample 
 With the calibrated loop urine was cultured on Cystein Lactose Electrolyte Deficient 
media (CLED) media for quantitative analysis to assess the microbial counts. Colony count 
of 10
5
 was taken as significant. The identification of pathogen was done by standard 
biochemical tests. Isolate suggestive of the yeast were subcultured on Sabouraud's dextrose 
agar and further identification was done by demonstration of germ tube; sugar fermentation 
and CHROM agar.  
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Sputum and Tracheal aspirate 
 Samples plated onto Mac Conkey, Chocolate agar plate (CAP)and Blood agar plates 
incubated at 37
o
C for 24 hrs. Chocolate agar plate was incubated in candle jar. The plates 
were examined after 24 hrs for presence of growth. Isolates were identified based on colony 
morphology, Gram stain and by standard biochemical reactions.  
 
 Body fluid was inoculated onto Mac Conkey, CAP and BAP incubated at 37
o
 C for 
24 hours and observed for growth. Figures: 2 and 3 exhibits the Klebsiella pneumoniae 
colony on MAC plate and the biochemical reactions. Figures 4 shows the Non lactose 
fermenting colonies of Acinetobacter boumannii and Figure: 5 shows its biochemical 
reactions. 
 
Flow Chart for processing of sample 
 
Blood 
 
10 mL each from 2 different sites, inoculated into 50 ml of BHI broth 
 
 
Incubated at 37°C 
 
 
Examined for signs of growth 
 
 
Subculture from 
 
BHI 
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            MAC and NA                 BAP 
 
         at 37°C for 48 hrs          at 37°C in CO2 
                (5%) for 48 hrs 
 
                    Examined for growth                Examined for growth 
 
   LF & NLF   Morphology, Hemolysis 
 
Biochemical tests were performed to identify the isolate 
 
 
Sputum, Sterile body fluids 
 
 
 
                               MAC                         CAP & BAP  
    
  at 37°C for 48 hrs                     at 37°C with 5% CO2 for 48 hrs 
     
         
Examined for growth 
 
 
 
Colony Morphology, 
Gram stain 
Biochemical Tests 
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Fig 2 : Klebsiella pneumoniae – on MacConkey agar 
 
 
 
 
Fig 3 : Klebsiella pneumoniae – Biochemical Reactions 
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Fig 4 : Acinetobacter boumannii – on MacConkey agar  
 
 
  
Fig 5 : Acinetobacter boumannii – Biochemical Reactions   
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Antibiotic Susceptibility Testing (AST) 
61 
Disc Diffusion Method: 
AST was performed for all the isolates by Kirby Bauer disc diffusion method as per 
Clinical and Laboratory Standards Institute (CLSI) guideline on Mueller-Hinton agar plates. 
Three to four colonies were inoculated in nutrient broth and incubated for two hours at 
37ºC, to bring the organism to logarithmic phase. The turbidity of the suspension was 
adjusted to 0.5 McFarland standards. Within fifteen minutes of preparation of the 
suspension, a sterile cotton swab was immersed in the suspension and the excess suspension 
was  removed by rotating the swab against the wall of the test tube. A lawn culture of the 
inoculum was made by streaking the swab over the surface of the plate in three directions. 
After about 10 to 15 minutes, the antibiotic discs were placed, five on each plate and 
incubated at 37 ºC for 20 to 24 hours. Zone of inhibition of bacterial growth around the 
antibiotic discs were measured using the Himedia scale. Interpretations were made using the 
CLSI, USA guidelines – January 2016, M100S. Control Strains: Staphylococcus aureus – 
ATCC 25923, E.coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853. 
 
Phenotypic screening method for Extended Spectrum Beta-lactamase (ESBL) 
62 
& 
Carbapenemase production 
 All the gram negative isolates were subjected to ESBL screening test using 
ceftazidime (30µg) and cefotaxime (30µg) and carbapenemase screening test using 
imipenem (10µg) and meropenem (10µg) discs by Phenotypic screening method.  
 
Phenotypic confirmatory test for ESBL production- Combined disc method 
 The isolates which were positive in the screening test were subjected to respective 
confirmatory tests using appropriate antibiotic discs. The phenotypic confirmation for 
ESBL production was done by testing the strain against ceftazidime (30µg) and 
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ceftazidime/clavulanic acid (30µg/10µg) Himedia, which were placed at a distance of 
20mm centre to centre on the Mueller-Hinton agar plate, incubated at 37ºC for 20-24 hours. 
The test isolate was considered to produce ESBL if the zone of inhibition around the 
ceftazidime-clavulanic acid disc was ≥5mm than the zone around ceftazidime disc alone. 
(Figure: 6) 
 
Carbapenemase detection by Modified Hodge Test (MHT)
63 
Isolates resistant to carbapenems was further processed by modified Hodge test to 
detect carbapenemase production. A lawn culture of 1:10 dilution 0.5 McFarland standard 
suspension of E.coli ATCC 25922 was done on to a Mueller Hinton Agar plate and allowed 
to dry for 3-5 minutes. A 10µg meropenem disc was placed in the center of the test area. In 
a straight line, the test organism was streaked from the edge of the disc to the edge of the 
plate and incubated at 37°C for 16-20 hours. Enhanced growth (Clover-leaf indentation) 
was considered as positive for carbapenemase production. (Figure: 7) 
 
Detection of MRSA-Disc Diffusion Method 
64 
 To detect Methicillin resistance in Staphylococcus aureus, with 0.5 McFarland 
standard suspension of each isolate, a lawn culture was performed onto Mueller Hinton 
Agar plate. 30 µg cefoxitin disc was placed in it by Kirby Bauer disc diffusion method and 
incubated at 37°C for 18 hours. The results are interpreted as per CLSI standards. 
 
 Staphylococcus aureus isolate with zone of inhibition ≤ 21mm was considered as 
MRSA and with inhibition zone size of ≥ 22mm was considered as Methicillin sensitive. 
For Coagulase Negative Stathylococci (CoNS) zone of inhibition of <24mm was interpreted 
as Methicillin resistant and that of ≥ 25mm was Methicillin sensitive.  
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Fig 6 : Phenotypic confirmation test for ESBL- Combined disc method 
 
 
 
Fig 7 : Modified Hodge Test (MHT)  
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Surveillance of Hand Hygiene Compliance (HHC) 
55 
 HHC was measured by direct observation. WHO observation form (indication 
related compliance with Hand Hygiene) was used as a monitoring tool. The investigator 
visited the IMCU at various time period and passively observed the hand hygiene behaviour 
of HCPs. During each 20 minutes period, minimum of 10 HH opportunities were observed. 
The surveyors counted hand hygiene opportunities and checked HCPs hand hygiene action 
in each opportunity. HHC was calculated by the below mentioned method. 
 
 Compliance with hand hygiene is the ratio of the number of performed actions to the 
number of opportunities and is expressed by the following formula: 
 
                  Performed actions 
Compliance (%) =  ---------------------------------- X 100 
                 Opportunities 
 
 Hawthorne effect or the observer effect i.e the alteration of behaviour by the subjects 
of a study due to their awareness of being observed was carefully avoided by doing practice 
observations before undertaking the original observation. 
 
 Measurement of the Consumption of Alcoholic hand rub products was done in 
association with the Implementation of WHO Multimodal Hand Hygiene Improvement 
Strategy. 
 
 Intervention of infection control practice in the IMCU was done for a period of four 
months from October 2016 to January 2017. 
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The intervention included: 
1. Focus Group Discussion (FGD) was conducted to assess the knowledge and attitude of 
HCPs on infection control and hand hygiene practices.With the help of the practical 
guide for Good Questions proposed by Richard Kruegar and Mary Anne Casey the 
prototype facilitation guide (Annexure iii) for FGD was prepared.
65
 
 
The facilitation guide included the following topics: general awareness and knowledge 
about standard work precaution, infection prevention and hand hygiene, their attitudes 
regarding their own and others hand hygiene practice at the site, and their ideas on 
challenges involved with infection control practices and preparedness for improving 
infection prevention efforts. Pilot testing, refinement, and validation of the survey 
questions were conducted. 
 
Participants were explained about the purpose of the study and ensured that their 
responses will be kept confidential. Written consent to participation was obtained from 
each participant.Discussions ranged in length from 30-45 minutes. The discussions 
were conducted in English and Tamil, recorded, transcribed and translated into English. 
(Figure:8) While conducting FGD, the facilitator used pre-determined question and 
established permissive environment. Six focus group discussions were held with 12 
nurses, 10 emergency care technicians and 5 doctors. Transcripts were analyzed by 
thematic content. 
 
2. Training and education of HCPs on infection control practices in the form of interactive      
educational sessions like demonstration, group discussion, video demonstration were 
conducted to cover various topics like Hand hygiene, Personal protective equipment 
(PPE), Health care associated infections and Introduction to Bundle approach, 
Universal/Standard work precaution, Catheter associated urinary tract infection, 
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Ventilator associated pneumonia, Central line associated blood stream infection, 
Multidrug resistant organism-antibiotic policy, Sterilization and disinfection, 
Biomedical Waste Management. 
 
Each training sessions lasted up to 30 minutes and tailored to the needs of different 
health care workers. The timing of the session was planned in discussion with the HCPs 
in such a way that it was conducted within their working hours but without affecting 
their routine work. (Figure: 9) The HCPs working in all the three shifts participated in 
the training sessions. 
 
The lecture had three sessions and the first session was for learning the residual and 
transient flora of hands and the role of HCPs hands in spreading infection. The second 
session was for understanding the WHO “Five Moments for Hand Hygiene” and the 
importance of hand hygiene.  
 
In the third session the importance of WHO recommended „My 5 moments of Hand 
hygiene‟ and seven steps of hygienic hand washing was demonstrated with the 
commercially available training tool (Figure: 10) having fluorescent cream mimicking 
germs on the hands and a Ultra violet torch to visualize the germs. 
 
After applying the fluorescent cream on hands, the HCPs were asked to wash their 
hands with water and soap in the way they routinely do and then the hands were 
checked under fluorescent lamp for the presence of fluorescent particles mimicking 
germs.The importance of 7 steps of hand hygiene was insisted and HCPs were made to 
adhere to the steps while washing their hands. The above mentioned same exercise was 
repeated. After the proper hygienic hand washing presence of very less number of 
fluorescent particles was demonstrated. (Figure: 11) 
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3. HCPs were trained and encouraged to participate in the preparation of written 
documents on procedures and protocols regarding Infection control practices, 
decontamination and disinfection of common equipment used in the IMCU. 
 
4. All the HCPs working in the IMCU were trained in maintaining charts in the form of  
monitoring tools(Annexure iv) on CAUTI and MDROs isolated from patients‟ clinical 
samples. User friendly monitoring tools were prepared after discussing and gathering 
inputs from the HCPs for the better compliance. 
 
5. Providing Information Education Communication Charts (IEC), materials at work place. 
Conducted a discussion with the HCPs on the requirements and usefulness of IEC 
material on infection control. Collected and compiled the information on end user 
specification for IEC material. Based on this,concepts for the preparation of 
posters(Annexure v) were developed. Accordingly posters were designed and displayed 
in the IMCU. 
 
6. Bundle approach was introduced for CAUTI prevention. Collection of five steps of 
interventions that have been recommended as best practices, based on evidence, in the 
prevention of CAUTI were taught to HCPs. Practicing urinary catheter insertion bundle 
and catheter maintenance bundle (Annexure vi) was emphasized. 
 
Post interventional phase 
 After the period of intervention, post interventional surveillance of the same 
infection control indicators was done for six months from February 2017 to July 2017. At 
the end of the interventional period, Knowledge, Attitude and Practice (KAP) of HCPs 
regarding Infection control and health care associated infections was assessed by using KAP 
Questionnaire survey(Annexure vii). 
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Fig 8 : Focus group discussion 
 
 
 
 
 
Fig 9 : Bed side training session 
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Fig 10 : Hand hygiene teaching tool 
 
 
 
 
 
Fig 11 : HH- practical demonstration using the teaching tool 
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RESULTS AND ANALYSIS 
 
RESULTS 
 
Table: 1 Age profile of study participants.  
 
S.No Age (Years) 
No. of Participants 
Pre Interventional phase 
(%) 
Post Interventional phase 
(%) 
1 12 – 20 77 (21) 47 (13) 
2 21 – 30 65 (18) 100 (28) 
3 31- 40 78 (22) 52(15) 
4 41-50 53 (15) 50 (14) 
5 51-60 47 (13) 47 (13) 
6 61-70 31 (9) 36 (10) 
7 71-86 8 (2) 21 (7) 
Total 359 353 
 
Majority of the patients for both the pre interventional phase (n=142, 40%) and for the post 
interventional phase (n=147, 42%) were from the age group 12-30 years. 
 
 
Table: 2 Age and Sex wise stratification of study participants.  
 
S.No 
Age (Years) 
 
No. of patients 
Pre Interventional Post Interventional 
Male Female Male Female 
1 12 – 20 38 39 22 25 
2 21 – 30 29 36 37 63 
3 31- 40 48 30 24 28 
4 41-50 27 26 24 26 
5 51-60 30 17 26 21 
6 61-70 13 18 24 12 
7 71-86 2 6 17 4 
Total 187 172 174 179 
 
male: female ratio was 1.01: 1. 
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Table: 3 Nature of specimen. 
 
 
S.No 
 
Nature of specimen 
No. of specimen 
Pre Interventional phase 
(%) 
Post Interventional 
phase (%) 
1 Urine 168 (38) 130 (29) 
2 Blood 165 (38) 157 (36) 
3 Tracheal Aspirate 53 (12) 89 (20) 
4 Sputum 28 (6) 29 (7) 
5 CSF 12 (3) 26 (6) 
6 Ascitic Fluid 7 (2) 4 (1) 
7 Pleural Fluid 6 (1) 6 (1) 
 Total 439 441 
 
No significant difference in the nature of distribution of specimen except that there was a 
68% increase in Tracheal aspirate sample in the post intervention phase. 
 
 
Table: 4 Pattern of Bacterial isolates from various clinical specimens - Baseline data 
 
Organisms 
Urine 
(%) 
Blood 
(%) 
Tracheal 
aspirate 
(%) 
Sputum 
(%) 
Sterile 
Fluid 
specimen 
(%) 
Total(%) 
Klebsiella 
pneumoniae 
4 (13) 5 (16) 14 (45) 7 (23) 1 (3) 31 (36) 
Acinetobacter spp. 2 (12.5) 2 (12.5) 10 (63) 1 (6) 1 (6) 16 (18) 
Pseudomonas spp. 1 (8) 0 6 (46) 6 (46) 0 13 (15) 
E.coli 5 (71) 2 (29) 0 0 0 7 (8) 
Klebsiella oxytoca 4 (100) 0 0 0 0 4 (5) 
P. mirabilis 1 (100) 0 0 0 0 1 (1) 
Citrobacter koseri 0 0 0 1 (100) 0 1 (1) 
Enterococcus spp. 3 (50) 3 (50) 0 0 0 6 (7) 
Staphylococcus 
epidermidis 
0 6 (100) 0 0 0 6 (7) 
Staphylococcus 
aureus 
0 0 2 (100) 0 0 2 (2) 
Total 20 (23) 18 (20.6) 32 (36.7) 15 (17) 2 (2.2) 87 
 
Klebsiella pneumoniae 31 (36%) was the predominant pathogen followed by Acinetobacter 
spp. 16(18 %).  
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Table: 5 Pattern of Bacterial isolates from various clinical specimens – post 
intervention data 
 
Organisms 
Urine 
(%) 
Blood 
(%) 
Tracheal 
aspirate 
(%) 
Sputum 
(%) 
Sterile 
Fluid 
specimen 
(%) 
Total 
(%) 
Acinetobacter spp. 2 (7) 6 (20) 16 (53) 6 (20) 0 30 (36) 
Klebsiella pneumoniae 2 (8) 4 (16) 12 (48) 6 (24) 1 (4) 25 (30) 
Pseudomonas spp. 1 (6.2) 0 13 (81) 1 (6.2) 1 (6.2) 16 (19) 
E.coli 4 (80) 0 0 1 (20) 0 5 (6) 
Klebsiella oxytoca 1 (50) 0 1 (50) 0 0 2 (2.3) 
Enterococcus spp. 1 (50) 1 (50) 0 0 0 2 (2.3) 
Citrobacter koseri 1 (100) 0 0 0 0 1 (1) 
Staphylococcus 
epidermidis 
0 2 0 0 0 2 (2.3) 
Staphylococcus aureus 0 1(100) 0 0 0 1 (1) 
Total 12 (14) 14 (17) 42 (50) 14 (17) 2 (2) 84 
 
Acinetobacter spp. 30(36%) was the predominant pathogen followed by Klebsiella 
pneumoniae 25(30%).Tracheal aspirate is the major source for the isolation of 
Acinetobacter spp. in both the phases 
 
Table: 6 Spectrum of microorganisms isolated in the study 
Organisms Baseline data (%) Post intervention data (%) 
Klebsiella pneumoniae 31 (28) 25 (26) 
Acinetobacter spp. 16 (14) 30 (31) 
E.coli 7 (6) 5 (5) 
Pseudomonas spp. 13 (12) 16 (17) 
Klebsiella oxytoca 4 (4) 2 (2) 
P. mirabilis 1 (1) 0 
Citrobacter koseri 1 (1) 1 (1) 
Enterococcus spp. 6 (5) 2 (2) 
Staphylococcus 
epidermidis 
6 (5) 2 (2) 
Staphylococcus aureus 2 (2) 1 (1) 
Candida non albicans 19 (17) 10 (10) 
Candida albicans 5 (5) 2 (2) 
Total 111 96 
There was no significant difference between infection rate between base line and the post 
interventional phase.  p =0.218.  
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Table: 7 Distribution of Gram Positive organisms among various clinical specimens 
 
Organisms 
Base line Post interventional 
Total 
Urine Blood 
Tracheal 
Aspirate 
Urine Blood 
Tracheal 
Aspirate 
Staphylococcus 
aureus 
0 0 2 0 1 0 3 
Enterococcus 
feacalis 
3 2 0 0 1 0 6 
Enterococcus 
feacium 
0 1 0 1 0 0 2 
Staphylococcus 
epidermidis 
0 6 0 0 2 0 8 
Total 3 9 2 1 4 0 19 
 
In the pre interventional phase, 14(16%) Gram positive organisms were isolated out of 87 
and in the post interventional phase, 5(6%) Gram positive organisms were isolated out of 84 
bacterial isolates. 
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Fig: 12 Bacterial Profile of both the phases of the study  
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Table: 8 Spectrum of microorganisms isolated from CAUTI – Baseline surveillance 
 
Organisms Number (%) 
E.coli 5 (11) 
Klebsiella oxytoca 4 (9) 
Klebsiella pneumoniae 4(9) 
Acinetobacter spp. 2 (5) 
Pseudomonas spp. 1 (2) 
P. mirabilis 1 (2) 
Enterococcus feacalis 3 (7) 
Candida non albicans 19 (43) 
Candida albicans 5 (11) 
Total 44 
 
  
Bacterial pathogen was identified in 17 (41 %) of patients and in 24 (59 %) patients 
Candida species were isolated. Out of 17 patients 3 patients had 2 bacterial isolates each 
with significant count. 
 
Table: 9 Spectrum of microorganisms isolated from CAUTI – post interventional 
surveillance 
 
Organisms Number (%) 
E.coli 4 (17) 
Klebsiella pneumoniae 2 (8) 
Acinetobacter spp. 2 (8) 
Klebsiella oxytoca 1 (4) 
Pseudomonas spp. 1 (4) 
Citrobacter koseri 1 (4) 
Enterococcus feacium 1 (4) 
Candida non albicans 10 (42) 
Candida albicans 2 (8) 
Total 24 
 
Candida non albicans was the predominant isolate
 
followed by E.coli in both the phases 
among the CAUTI specimen.  
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Table: 10 Descriptive analysis of catheter days – Baseline surveillance 
 
Days of urinary 
catheterisation 
No of 
patients 
No of UTI 
detected 
Total No of 
Device Days 
Infection 
rates (%) 
Mean 
duration of 
catheter use 
≤3 29 3 84 1.7 2.8 
4 - 7 56 11 344 6.5 6.15 
>7 83 27 1420 16.07 17.10 
Total 168 41 1848 24.40 11 
 
 
The rate of development of CAUTI was higher as the duration of catheterization increased. 
p value 0.033946, Chi square value 6.766 
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Fig:13  CAUTI isolates Pre & Post interventional analysis  
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Table: 11 Descriptive analysis of catheter days - post interventional surveillance 
 
CAUTI rate was calculated as 22 and 21 per 1000 catheter days for pre interventional phase 
and post interventional phase respectively. There was no statistically significant difference 
between infection rates of both the phases. p=0.127. 
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Fig:14 Comparison of Catheter use and Infection rate 
pre intervention Post intervention
Days of urinary 
catheterisation 
No of 
patients 
No of UTI 
detected 
Total No of 
Device Days 
Infection 
rates (%) 
Mean duration 
of catheter use 
≤3 20 0 44 0 1.4 
4 - 7 47 7 242 14.8 5.1 
>7 63 17 850 27 13.49 
Total 130 24 1136 18.46 8.7 
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Table: 12 Trend analysis of CAUTI rate during the Pre and Post interventional 
phases. 
 
Phase 
CAUTI rate 
Apr & May June & July 
Pre intervention 2016 28.04 34.78 
Post intervention 2017 16.32 9.52 
p value 0.184 0.012 
 
Trend analysis of CAUTI rate was done by comparing 4 data i.e April, May, June and July 
in 2016 and 2017, found to be statistically significant. (p value was 0.012 for the months 
June, July of 2016 and 2017). 
 
Table: 13   Baseline and Post interventional evaluation of Tracheal Aspirate specimen. 
 
Nature of 
specimen 
Baseline post interventional 
Total no. of 
patients 
No. of culture 
positives (%) 
Total no. of 
patients 
No. of culture 
positives (%) 
Tracheal 
Aspirate 
53 32(60) 89 42(48) 
 
Number of Tracheal aspirate specimen has increased in the Post interventional evaluation 
by 68%. 
 
Table: 14 Baseline and Post interventional evaluation of infection rate in the study 
group. 
 
Urine specimen Blood specimen 
Respiratory & 
fluid specimen 
Total 
no. of 
patients 
No. of 
culture 
positives 
(%) 
Total 
no. of 
patients 
No. of 
culture 
positives 
(%) 
Total 
no. of 
patients 
No. of 
culture 
positives 
(%) 
Baseline data 168 41(24) 165 18(11) 106 49(46) 
Post interventional 
data 
130 24(18) 157 14(9) 154 58(38) 
p value 0.114 0.550 0.858 
 
The difference in the infection rate of urine, blood and respiratory and fluid specimen 
between pre interventional phase and post interventional phase was not statistically 
significant. 
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Table: 15 Trend analysis of Blood stream infection rate among the study population. 
Phase 
Blood stream infection  rate 
Apr & May June & July 
Pre intervention 2016 10 10.5 
Post intervention 2017 11.1 6.8 
p value 0.829 0.591 
 
 
Table: 16 Trend analysis of culture positivity of respiratory specimen during the study 
period. 
 
Phase 
Infection rate- Respiratory specimen 
Apr & May June & July 
Pre intervention 2016 64.1 70 
Post intervention 2017 47.6 41.11 
p value 0.32 0.15 
 
 
Table: 17 Distribution of MDR pathogens. 
 
Specimen 
Baseline Post interventional 
Total no. of 
organisms 
No. of MDR 
organisms 
(%) 
Total no. of 
organisms 
No. of MDR 
organisms 
Tracheal aspirate 32 13 (32.5) 42 18 (54.5) 
Blood 18 8 (20) 14 6 (18) 
Urine 20 9(22) 12 5(15) 
Sputum 15 9 (22.5) 14 3 (9) 
Body fluids 2 1 (2.5) 2 1 (3) 
Total 87 40 84 33 
 
Tracheal aspiration was the predominant specimen from which majority of the MDR 
pathogens were isolated. 
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Table: 18 Nature of distribution of MDR pathogens. 
 
Specimen Organisms 
Baseline Post interventional 
Total no. 
of 
organisms 
No. of 
MDR 
organisms 
Total no. of 
organisms 
No. of MDR 
organisms 
Urine 
E.coli 5 2 4 0 
Klebsiella 
pneumoniae 
4 1 2 1 
Klebsiella oxytoca 4 2 1 1 
Acinetobacter spp. 2 0 2 2 
Pseudomonas spp. 1 1 1 1 
Proteus mirabilis 1 0 0 0 
Citrobacter koseri 0 0 1 0 
Enterococcus spp. 3 3 1 0 
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Fig:18  Comparison of MDR isolates 
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Blood 
Klebsiella 
pneumoniae 
5 3 4 2 
E.coli 2 1 0 0 
Acinetobacter spp. 2 1 6 2 
Enterococcus spp. 3 1 1 0 
Staphylococcus 
aureus 
0 0 1 1 
Staphylococcus 
epidermidis 
6 2 2 1 
Tracheal 
Aspirate 
Klebsiella 
pneumoniae 
14 7 12 5 
Klebsiella oxytoca 0  1 0 
Acinetobacter spp. 10 5 16 6 
Pseudomonas spp. 6 0 13 7 
Staphylococcus 
aureus 
2 1 0 0 
Sputum 
Klebsiella 
pneumoniae 
7 3 6 1 
E.coli 0 0 1 0 
Acinetobacter spp. 1 1 6 0 
Citrobacter koseri 1 1 0 0 
Pseudomonas spp. 6 4 1 2 
Body 
Fluid 
Klebsiella 
pneumoniae 
1 0 1 1 
Acinetobacter spp. 1 1 0 0 
Pseudomonas spp. 0 0 1 0 
Total 87 40 (46%) 84 33 (39%) 
 
The difference in the distribution of MDR pathogens between Baseline and Post 
interventional was not statistically significant. p=0.376. 
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Table: 19 Distribution of Carbapenemase producing organisms among the study 
group - Baseline data. 
 
Nature of Specimen 
Total number of 
gram negative 
isolates 
Carbapenemase Producing 
Organisms 
Number 
Tracheal Aspirate 30 
Acinetobacter spp. 4 
Klebsiella pneumoniae 1 
Urine 17 Klebsiella pneumoniae 2 
Sputum and Fluid 
specimen 
17 
Klebsiella pneumoniae 1 
Pseudomonas spp. 1 
Blood 9 Acinetobacter spp. 1 
Total 73  10 
 
 
Table: 20 Distribution of Carbapenemase producing organisms among the study 
group – post intervention data. 
 
Nature of Specimen 
Total number of 
gram negative 
isolates 
Carbapenemase producing 
Organisms 
Number 
Tracheal Aspirate 42 
Acinetobacter spp. 
Klebsiella pneumoniae 
4 
2 
Sputum and Fluid 
specimen 
16 - - 
Urine 11 Acinetobacter spp. 1 
Blood 10 Acinetobacter spp. 2 
Total 79  9 
 
In both the phases of this study Acinetobacter spp. was the predominant Carbapenemase 
producer.  (p =0.667 not significant) 
 
Table : 21 Distribution of resistant pattern among isolates. 
 
Resistant pattern Baseline (%) Post interventional (%) p value 
MDR 40 (46) 33 (39) 0.376 
ESBL 57 (78) 55 (70) 0.236 
Carbapenemase 
production 
10 (13.6) 9 (11.3) 0.667 
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Table: 22 Evaluation of Hand Hygiene Compliance. 
 
Observations 
No. of 
opportunity 
No. of performed 
action 
Percentage 
Baseline 200 44 22 
Post interventional 200 68 34 
 
 
Table: 23 Thematic content of focus group discussion 
 
S.no Major Theme Sub Category 
1 
Challenges with practice of 
infection control 
*Heavy work load 
*Knowledge of core concepts 
* Complacency 
2 Interventions to improve 
*Need for training 
* Designated infection control personnel 
* Monitoring 
 
 
Table: 24 Outcome analysis of post interventional KAP questionnaire study. 
 Knowledge (8 marks) Attitude (4 marks) Practice (8 marks) 
Mean(+/- STD 
deviation) 
6.5 (1.33) 3.1 (0.727) 4.6 (1.40) 
 
Table: 25 Summary table of population and Study findings. 
Data 
Pre interventional 
phase 
Post interventional 
phase 
No. of patients 359 353 
Male 187 174 
Female 172 179 
No. of urine specimen 168 130 
No. of blood specimen 165 157 
No. of respiratory & fluid specimen 106 154 
No. of Gram negative isolates 73 79 
No. of Gram positive isolates 14 5 
No. of fungal isolates 24 12 
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Data 
Pre interventional 
phase 
Post interventional 
phase 
Organisms isolated in CAUTI 44 24 
Total catheter days 1848 1136 
Mean duration of catheterization(days) 11 8.7 
CAUTI rate per 1000 catheter days 22 21 
CAUTI rate-Trend analysis of 4 data 
points 
34.7 9.5(p=0.012) 
No. of MDR pathogens 40 (46%) 33(39%)p=0.376 
No. of ESBL producers 57(78%) 55(70%)p=0.236 
No. of Carbapenemase producers 10(14%) 9(11%)p=0.667 
Hand Hygiene Compliance 22% 34%p=0.007 
 
ANALYSIS 
 In this prospective interventional study, 78(22%) patients enrolled were in the age 
group between 31- 40 years, followed by 77(21%) in the age group 12 – 20 years in the pre 
interventional phase. For the post interventional phase, 100 (21%) patients were from the 
age group 21-30 years. On the whole the observation showed that majority of the patients 
for both the pre interventional phase (n=142, 40%) and for the post interventional phase 
(n=147, 42%) were from the age group 12-30 years. [Table 1] 
 
 Age and sex wise stratification of the study participants is depicted in Table 2. There 
was no significant variation in male: female ratio (1.01: 1) among the participants. 
 
 A total of 439 consecutive specimen for the pre interventional phase and 441 
consecutive specimen for the post interventional phase were included during the study 
period, each phase lasted for six months. Nature and distribution of the specimen is 
discussed in Table 3. 
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 Pattern of microorganisms isolated from various clinical specimens for the pre 
interventional phase is tabulated in Table 4 and the post interventional phase is tabulated in 
Table 5. 
 
 Out of the 87 bacterial isolates obtained from clinical specimen in the pre 
interventional phase, 32 (37%) isolates were from tracheal aspirate and 20 isolates (23%) 
were from urine. In the post interventional phase, 84 bacterial isolates were cultured; of this 
42(50%) were from tracheal aspirate and 12 (14%) were cultured from urine specimen. Fig: 
12 depict the Bacterial Profile of both the phases of the study.  
 
 Table 6 compares the spectrum of microorganisms isolated in both the phases of the 
study. There was no significant difference in infection rate between base line and the post 
interventional phase.  p =0.218.  
 
 Klebsiella pneumoniae 31 (36%) was the predominant pathogen isolated in pre 
interventional phase followed by Acinetobacter spp. 16(18 %). Majority of the Klebsiella 
pneumoniae was grown from Tracheal aspirate (45%) followed by sputum (23%), blood 
(16%) and urine specimen (13%). 
 
 In the post interventional phase, Acinetobacter spp. 30(36%) was the predominant 
pathogen isolated followed by Klebsiella pneumoniae 25(30%). Tracheal aspirate was the 
major source for the isolation of Acinetobacter spp. in both the phases. 
 
 By the phenotypic characteristics, such as glucose oxidation, beta hemolysis and 
growth at 37
o
C & 42
o
C the Acinetobacter isolates were speciated. Of the total 46, catalase 
positive, oxidase negative non-fermenter isolates, 36(78%) were Acinetobacter boumannii, 
10(22%) were A.lwoffii and one isolate was A.hemolyticus. 
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Distribution of Gram Positive organisms among various clinical specimens is shown in 
Table 7. In the pre interventional phase, 14(16%) Gram positive organisms were isolated 
out of 87 and in the post interventional phase, 5(6%) Gram positive organisms were isolated 
out of 84 bacterial isolates. Enterococcus isolates were speciated by sugar fermentation 
(arabinose, raffinose, sorbital) tests, and Enterococcus feacalis 6 in number and 
Enterococcus faecium 2 in number were identified. 
 
 A total number of 41(24.40%) patients out of 168 clinically diagnosed CAUTI 
patients were culture positive with significant colony count in the pre interventional phase. 
Bacterial pathogen was identified in 17 (41 %) of patients and in 24 (59 %) patients 
Candida species were isolated. [Table 8]. Out of 17 patients 3 patients had 2 bacterial 
isolates each with significant count. So, 20 bacterial pathogens were isolated from 17 
patients.Among the fungal isolates Candida non albicans was the predominant organism 
isolated in 19 (79.2%) patients while Candida albicans was isolated only in 5(20.8%) 
patients. Among Candida non albicans, C. tropicalis 09(47%) was the predominant species 
followed by C. glabrata 05 (26%) C. krusei 03(15.7%) and C.parapsilosis 2(10.5%). 
 
 Spectrum of microorganisms isolated from clinically diagnosed CAUTI patients in 
the post interventional surveillance is given in the Table 9. Candida non albicans was the 
predominant organism isolated in 10 patients (42%) followed by Escherichia coli 4(17%). 
Infection rate was 18.4% Fig: 13 depict the comparison of spectrum of CAUTI isolates in 
Pre and Post interventional phases. 
 
 The descriptive analysis of catheter days in the pre interventional phase shows that 
the rate of development of CAUTI was higher as the duration of catheterization increased. p 
value 0.033946, Chi square value 6.766.Table 10. Comparison of mean duration of 
catheterization and infection rate in given in Fig: 14.  
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The total urinary catheterization day calculated for 168 patients in the pre interventional 
phase was 1848 days. The same was calculated as 1136 days for 130 patients in the post 
interventional phase[Table 11]. CAUTI rate was calculated as 22 and 21 per 1000 catheter 
days for pre interventional phase and post interventional phase respectively. There was no 
statistically significant difference between infection rates of both the phases. p=0.127. 
 
 Trend analysis of CAUTI rate was done by comparing 4 data points‟ i.e CAUTI rate 
during the pre-interventional phase (April, May, June and July in 2016) and the same 
months in the post interventional phase 2017. It was found to be statistically significant (p 
value was 0.012 for the months June, July of 2016 and 2017). [Table 12] 
 
 Baseline and Post interventional evaluation of Tracheal Aspirate specimen number 
and culture positivity is discussed in Table 13. Number of Tracheal aspirate specimen has 
increased in the Post interventional evaluation by 68%. 
 
 The difference in the infection rate of urine specimen (p=0.114), blood specimen 
(p=0.550) and respiratory and fluid specimen (p=0.858) between pre interventional phase 
and post interventional phase was not statistically significant. [Table 14] 
 
 Table 15&16 discusses the trend analysis of Blood stream infection rate and the 
culture positivity of respiratory specimen between Pre and Post interventional phases during 
the study period. Line diagram for the Trend analysis of infection rate of urine, respiratory 
and blood specimen is given in Fig: 15, 16, 17. 
 
 Table 17& 18 depicts the nature and distribution of MDR pathogens among study 
isolates. The difference in the distribution of MDR pathogens between Baseline and Post 
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interventional was not statistically significant. p=0.376. The rate of isolation of MDR 
pathogens both in pre and post interventional phases compared in Fig: 18. 
 
 Distribution of Carbapenemase producing organisms among the study group, 
Baseline data and Post interventional data is presented in Table 19 and Table 20 
respectively. In both the phases of this study Acinetobacter spp. was the predominant 
Carbapenemase producer and Tracheal aspiration was the predominant specimen from 
which it was isolated. p =0.667 not significant. 
 
 Distribution of resistant pattern among isolates is compiled in Table 21.Though 
there was a difference in number of ESBL isolates between two phases of study it was not 
significant. Among the gram positive organisms, Methicillin Resistant was diagnosed in 3 
out of 8 Staphylococcus epidermidis isolates in this study. Among the Staphylococcus 
aureus, one out of 3 was Methicillin resistant. 
 
 Evaluation of Hand Hygiene Compliance showed a statistically significant 
difference p=0.007. [Table 22] 
 
 Thematic content of focus group discussion is illustrated in Table 23. Two major 
themes evolved were Challenges with practice of IC and Interventions to improve. 
 
 Table: 24 discusses the outcome analysis of post interventional KAP questionnaire 
study. T test value for knowledge to attitude, knowledge to practice and attitude to practice 
is 2.04. p value <0.001. 
 
 Only 44% (7 out of 16) of participants were aware about the major infection control 
related problem of their work place.  
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 Practising universal precautions was protective as per 75% of participants, it was a 
compulsory affair according to 25% of participants. 
 
 According to 69% of participants inadequate supply of alcoholic hand rub was the 
major barrier to HHC. Heavy work load (19%) and lack of accessible place of hand rub 
(12%) were the other barrier for poor HHC. 
 
 As per the statement by 37% of participants HH was not adequately practiced by 
other staff members while 63% of them expressed their satisfaction about HH practice of 
other staff members. 
 
 Summary of the study population and the study findings of both the phases is given 
in Table: 25. 
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DISCUSSION 
 The study was conducted in a 22 bedded IMCU of a tertiary care hospital, which 
also included 5 bedded high dependency unit.  
 
 There were 5 medical officers and 2 head nurses with 20 staff nurses posted in 3 
shifts round the clock. The staffs were not exclusively posted in IMCU, they were also 
catering the adjacent 22 bedded toxicology intensive care unit. Two Medical post graduate 
students and two interns per shift were posted on monthly rotation. Apart from this, 4 
student nurses and 4 emergency care technician students, 2 injection staff and one lab 
technician were posted regularly in the day time shifts. Four sanitary workers were also 
posted in 3 shifts.  
 
 Allied health care personnel like physiotherapist, hemodialysis technician, dietician 
and Anesthetist, ENT surgeon and many other qualified medical persons from various 
speciality departments were the floating population catering the IMCU patients on call. 
 
 The present study was designed as non-randomized, quasi-experimental which is 
commonly used in hospital epidemiology: i.e. interrupted time series without control 
groups.The interrupted time series is the predominant study design for infectious disease 
epidemiology, especially in the hospital setting. The ORION statement: guidelines for 
transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection 
emphasizes thoroughness in reporting: as well as the usual what was done and when it was 
done, for such quasi-experimental research.
18 
 
 Base line or Pre-interventional evaluation of the infection control indicators such as 
HHC, CAUTI rate and MDRO rate were calculated for a period of six months from April 
2016 to September 2016. This was followed by 4 months intervention, from October 2016 
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to January 2017, then Post interventional surveillance of the same indicators were done for 
a period of six months from February 2017 to July 2017. 
 
 There was no significant difference in the number, age and sex distribution of 
patients in both the phases (pre and post intervention) of this study. [Table 1&2]Also there 
was no significant difference in the nature of distribution of specimen and pattern of 
microorganisms isolated from the various clinical specimen except that there was a 68% 
increase in Tracheal aspirate sample in the post intervention phase. [Table3, 4&5]  
 
 In this study, among the bacterial isolates, 14(16%) were Gram positive organisms 
and 73(84%) were Gram negative organisms in the pre interventional phase and in the post 
interventional phase 5(6%) were Gram positive , 79(94%) were Gram negative [Table 
6&7]. This is similar to other hospital based studies.
2
 In an Indian study conducted in a 
tertiary care centre, by Jaggi et al., among the study isolates, Gram-negative (80.8%) 
showed a clear preponderance than Gram-positive pathogens (19.9%). 
66 
 
 In the WHO Global priority list of Antibiotic resistant bacteria to guide research, 
discovery and development of new antibiotics, the organisms causing HCAI are grouped 
under priority 1 critical list. In that list, 9 out of 12 families are of the “gram-negative” type 
and are MDROs. Top of the list is Escherichia coli, the leading cause of urinary tract 
infections. 
67 
 
 In this study the difference in the spectrum of bacterial isolates in pre and post 
interventional phase was not significant. p value 0.218.[Table 6] Among the Gram-negative 
isolates, K.pneumoniae (36%) was the predominant bacterial isolate in the pre 
interventional phase followed by Acinetobacter spp. (18%) and Pseudomonas spp. (15%). 
In the post interventional phase Acinetobacter spp. (36%) was the predominant followed by 
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K.pneumoniae (30%) and Pseudomonas spp. (19%). This spectrum is similar to nosocomial 
pathogens isolated in other Indian studies.
68, 69 
 
 In the present study, among the CAUTI specimen, a total number of 41(24.40%) 
patients out of 168 were culture positive with significant colony count. Bacterial cause was 
identified in 17 (41 %) patients and in 24 (59 %)patients, Candida species were isolated, in 
the pre interventional phase. In the post interventional phase, 24 (18%) patients out of 130 
had significant bacteriuria and bacterial cause was identified in 12(50%) of them. 
 
 Candida non albicans was the predominant isolate
70 
followed by E.coli in both the 
phases among the CAUTI specimen.[Table 8&9]Among the bacterial isolates, Gram-
negative bacilli represented the most common (85% in pre intervention and 91% in post 
interventional phase). 
 
 The descriptive analysis of catheter days in the pre interventional phase shows that 
the rate of development of CAUTI was higher as the duration of catheterization increased. p 
value 0.033946, Chi square value 6.766.[Table10] 
 
 The mean duration of catheterization in this study was 11 days and 8.7 days in pre 
and post interventional phases respectively. The mean duration of catheterization decreased 
by 27%, resulting in 2.30 fewer days of catheterization per patient in the post intervention 
group. [Table 10 &11] 
 
 In a hospital-based prospective study on risk factors of CAUTI, the mean duration of 
catheterization was 4.8 days and 28/125 (22.4%) of patients developed a symptomatic 
urinary tract infection during the period of follow up. 
71 
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 CAUTI rate in the present study calculated at the end of the pre interventional and 
the post interventional phase was 22 and 21 per 1000 catheter days respectively. But the 
trend analysis of data points in the months of June and July in both the phases showed 
decrease in the urinary infection rate from 34.78 to 9.52 which was significant. [Table12] It 
was not the same with April and May months of both the phases. This explains the phase of 
reluctance and the time period required by HCPs to adapt to the newly introduced CAUTI 
bundle concepts.  
 
 The decrease in mean catheterisation rate and CAUTI rate leads to decrease in 
IMCU stay and in turn decreases the use of broad spectrum antibiotics. Practising the IC 
methods such as HH and CAUTI bundle approach ultimately leads to cost effective patient 
care and patient safety. Studies proved that patients who had longer ICU stays had higher 
rates of infection, especially infections due to resistant Staphylococci, Acinetobacter spp., 
Pseudomonas species, and Candida species.
72 
 
 Inadequate infection prevention and control practices provide greater opportunities 
for new drug resistant infections to emerge in healthcare settings. In turn, a high incidence 
of such infections results in an increased demand for broad spectrum and reserve antibiotics, 
which also contributes to increased drug resistance.
73 
 
 The difference in the infection rate of blood specimen (p=0.550) and respiratory and 
fluid specimen (p=0.858) between pre interventional phase and post interventional phase 
were not statistically significant. [Table13&14] Also the trend analysis of data points for the 
blood stream infection rate and culture positivity rate of respiratory specimen in the pre and 
post intervention phase were not significant.[Table15&16] However the significant 
reduction in the CAUTI rate in the trend analysis explains the importance of effective 
introduction of bundle approach for the prevention of device associated infections. 
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 In a study by Amira Ezzat Khamis Amine et al., to evaluate the intervention 
program to prevent CAUTI, the presence of a statistically significant strong negative 
correlation between the adherence to the urinary catheter care maintenance bundle elements 
and the CAUTI rate, suggests their strong role in the prevention of CAUTI. Adherence to 
recommended CAUTI preventive practices (bundle) should become part of a culture of 
patient safety. 
74 
 
 According to a study by Jaggi and Sissodia conducted in the year 2012 in India, the 
most common labour and cost effective CAUTI prevention measures were adherence to the 
urinary catheter bundle components (indication for catheter insertion and change, asepsis 
maintenance during and after the catheter insertion and avoiding urine reflux) and hand 
hygiene practices. 
75 
 
 In a Taiwan study, the rate of overall HAI decreased from 3.7% to 3.1% (P < .05), 
urinary tract infection rate decreased from 1.5% to 1.2% (P < .05), and respiratory tract 
infection rate decreased from 0.53% to 0.35% (P < .05) after the implementation of WHO 
multimodal hand hygiene improvement strategy. 
76
 In the present study, reduction in 
CAUTI rate was significant however the reduction in the infection rate of respiratory 
specimen was not significant. p= 0.858 
 
 HCAI caused by MDR pathogens and extensively drug-resistant Gram-negative 
pathogens represent a major threat worldwide.
57
 In general, MDRO are those organisms 
which are resistant to at least one agent in at least three antimicrobial classes of 
Cephalosporins, β-lactam/β-lactamase inhibitors, Carbapenems, Fluoroquinolones, 
Aminoglycosides 
77
and are considered to be epidemiologically important as these organisms 
are associated with treatment failure and increased morbidity.
78 
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 Methicillin-resistant Staphylococcus aureus [MRSA], Vancomycin resistant 
Enterococcus and Carbapenem-resistant Enterobacteriaceae are some of MDROs. MDR is 
also common and increasing among non-fermenting Gram-negative bacteria. The ESKAPE 
microorganisms, -Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp., point out the 
„eskape‟ effect from the action of antibacterial agents.79 
 
 According to a study conducted by Puneet Butt et al., most resistant MDR isolates 
were obtained from acute wards (42.9) and ICU (29.5) followed by other wards.
80
In that 
study the most common specimen in which these resistant isolates were obtained was urine 
followed by tracheal aspirate. 
80 
 
 In the present study, approximately 40% of isolates in the pre intervention phase and 
39% in the post intervention phase were MDR. This is in contrast to a study by Giang M et 
al., in which 85% were found to be multiple-drug resistant.
82  
Among the MDR pathogens, 
maximum number were isolated from Tracheal aspirate specimen both in pre-interventional 
phase (32.5%) and in post interventional phase (54.5%). [Table 17] K.pneumoniae (33%) 
was the most common MDR pathogen followed by Acinetobacter spp. (25%) and 
Pseudomonas spp. (20%). Rate of isolation of MDR pathogen decreased from 46% in the 
pre-interventional to 39% in the post interventional phase.p value is 0.376. [Table 18] In a 
south Indian study conducted by Kailash et al., 55.7% of IMCU isolates were MDR and the 
most common organism isolated was Pseudomonas spp. (19.1%) followed 
by Acinetobacter spp. (17.5%) from tracheal aspirate.
81  
 
 Among the MDR Gram negative isolates, highest resistance was observed to 
Ampicillin, lowest resistance was observed to Amikacin, Cefaperazone/Sulbactam, 
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Piperacillin/Tazobactam and Imipenem. Among the Gram negative Enterobacteriaceae 
isolates, 80% were susceptible to Amikacin, 72% to Cefaperazone/Sulbactam, 68% to 
Ciprofloxacin and 50% to Gentamicin. Only 20% of them were susceptible to Cefotaxime 
and 8% to Ampicillin. 
 
 The non-fermenter isolates were found to be susceptible to Amikacin 
(70%)Piperacillin/Tazobactam (60%), Ciprofloxacin (52%), Gentamicin (48%) and only 
24% of them were susceptible to Ceftazidime. This is similar to studies conducted in 
various parts of the globe, in which the highest susceptibility rates recorded 
for K.pneumoniae, P.aeruginosa and Acinetobacter species were to Amikacin and 
Imipenem while the lowest susceptibility rates were to ampicillin, ceftriaxone, ceftazidime, 
ciprofloxacin and gentamicin. 
83,84 
 
 Amikacin was the most effective antibiotic against both Enterobacteriaceae isolates 
(80%) and non-fermenter isolates (70%) followed by Imipenem. This is similar to an 
Indonesian study in which Amikacin was the most effective (84.4%) antibiotic against P. 
aeruginosa followed by Imipenem (81.2%).
85 
 
 The susceptibility rates to Piperacillin/Tazobactam and Cefaperazone/Sulbactam 
were on average about 60% and 72% respectively. This may be due to increase usage of the 
antibiotic.
86 
 
 In this study, among the Gram positive organisms, all the MRCoNS (37.5%)isolates 
and  33%  of MRSA were obtained from blood. This is similar to a study conducted in 
Intensive Care Units of a Tertiary Care Hospital in Southern India, in which about (40.6%) 
of Staphylococcus aureus were found to be MRSA.
81 
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 Both MRSA and MRCoNS exhibited higher resistance to Penicillin-G (91%), 
Ampicillin (81%), Ciprofloxacin (64%) and all were sensitive to Vancomycin and 
Linezolid. All the Enterococcus spp. isolated from CAUTI patients were found to be 
multidrug resistant and were found to be sensitive to Vancomycin. Since the number of 
Gram-positive isolates was < 16%, this may not be the true picture to be considered as 
significant. All the Staphylococcus epidermidis isolates were obtained from blood culture 
and pathogenicity of the isolate was confirmed by isolating the same organism with the 
consecutive blood samples collected from the patient and by clinical correlation. 
 
 In an Indian study conducted by Gopalakrishnan et al., over an 8 year period in a 
tertiary care hospital, on antimicrobial susceptibility and hospital acquired infections, the 
overall MRSA prevalence was 40-50% and 17% of Staphylococcus aureus was isolated 
from catheter related blood stream infections (CRBSIs) in that centre. 
87 
 
 A high proportion of Acinetobacter spp. (50%) in the pre intervention and in the 
post intervention phase (33%) was multidrug resistant. For Klebsiella pneumoniae 45% and 
40% were multidrug resistant in the pre and post intervention phase respectively.This is 
similar to another hospital based study conducted in Delhi, in which high rates of multidrug 
resistance were observed in Acinetobacter spp., Klebsiella spp. and Escherichia coli 
isolates.
88 
 
 Among the Carbapenemase producing organisms, Acinetobacter spp.(63%) was the 
predominant pathogen followed by K.pneumoniae (32%). In a study by YanlingXu et al., 
stably escalating trend of resistance rates to imipenem and meropenem was reported 
in Enterobacteriaceae.
89 
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 In both the phases of this study, Acinetobacter spp. was the predominant 
Carbapenemase producer and Tracheal aspiration was the predominant specimen from 
which it was isolated. p =0.667 not significant.[Table19&20] This is similar to a study on 
MDR pathogens, in which the prevalence of Carbapenem resistance in Acinetobacter spp. 
was found to be 85%. 
90 
 
 In a 4 year study conducted in western India on trends of Acinetobacter spp., a high 
proportion of MDR and ESBL producing non susceptible Acinetobacter spp. were isolated 
from respiratory specimen.
91 
 
 The ESBL producing Gram negative isolates were 78% and 70% in the pre-
interventional phase and in the postinterventional phase. [Table 21] In a study by 
Pottahilshinu et al., the incidence of ESBL-producing organisms among clinical isolates of 
urinary tract infections and wound infections was found to be 72.41%.
92 
In another study, 
among the 150 non repetitive Gram negative isolates, 102 (68%) were found to be ESBL 
producers and prevalence of ESBLs was maximum in ICU (34.2%). 
93 
 
 Hand washing is the easiest and oldest strategy to prevent nosocomial infections. 
Moreover, scientific evidence suggests that the compliance of hand hygiene by HCP with 
alcohol based hand rub reduces the HCAI rate and is more acceptable and easier to use.
94
 In 
spite of all the aforementioned facts, poor compliance with HH recommendations among 
HCP is a worldwide problem.The results of researches conducted in the public sector, even 
in developed countries, also showed poor performance of nurses and other health workers in 
hand hygiene.
95,96 
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 In the present study, HHC rate in pre interventional phase was 22% and it increased 
to 34% in the post interventional phase. (p <0.010). [Table 22] Also there was a 40% 
increase in the requirement of alcohol based hand rub in the post intervention phase.  
 
 Many studies claim that HHC improvement is temporary after educational 
interventions.
97,98
 In a study by Huang et al,
99
 4 months post-education, HHC significantly 
improved (P<0.001) for the nurses in the experimental group compared to the control group 
which is similar to this study. HHC was found to be highest among nurses (63%) followed 
by other staff (56%) and doctors (48%). This is similar to a study conducted in a tertiary 
care hospital in which nurses were found to be more compliant to HH practice than 
doctors.
100 
 
 In an another study by Jui-Kuang Chen et al , overall HHC increased from 62.3% to 
73.3% after 1 year of intervention (P < .001).
76  
In contrast, Gould et al found that 3 months 
after the education intervention, there was no significant improvement in the number of 
essential hand hygiene episodes in the intervention.
101 
 
 In this study, 69% of participants stated that the inadequate supply of alcoholic hand 
rub was the common barrier to HH compliance. Heavy work load (19 %) and lack of easy 
access to hand rub (12 %)were the other reasons for poor compliance. 
 
 In an article reviewing the reported barriers to appropriate hand hygiene and factors 
associated with poor compliance, the author has stated that in high-demand situations, hand 
rub with an alcohol-based solution appears to be the only alternative that allows a decent 
compliance.
102 
Easy access to hand hygiene product is also a necessary prerequisite for 
appropriate hand-hygiene behaviour.  
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 In a two-arm cluster randomised controlled trial, the MRSA prevalence in the 
intervention arm dropped in the initial phases than control arm and became steady 
afterwards. Though the HHC improved significantly, the difference in MRSA prevalence 
and transmission between the two arms was not statistically significant.
103 
 
 This is very similar to the present study with significant improvement in HHC 
(p=0.010) though the improvement in other infection control indicators was not statistically 
significant except the CAUTI rate. 
 
Challenges to the infection control 
 According to recommendation by European society of intensive care medicine 
working group, 3 level of care (LOC) is proposed. Patients with 2 or more acute vital organ 
failure are categorized in LOC III (highest), patients requiring monitoring and device 
related support with one vital organ failure are grouped in LOC II, and LOC I (lowest) 
represents patients with signs of organ dysfunction necessitating continuous monitoring 
with minor device support. For different LOC, appropriate minimum nurse/patient ratio 
proposed is, LOC III - 1/1, LOC II - 1/2 and for LOC I is 1/3. 
104 
 
 The typical nurse to patient ratio in this study was 1:4 at morning and 1:6 at 
afternoon and night shifts. This is similar to other studies in which, insufficient funding and 
human resources, hospital overcrowding, and low nurse-to-patient ratios even in intensive 
care units were reported as important challenges in successful implementation of infection 
control and prevention practices in Indian hospitals.
2, 105 
 
 Understanding the perspectives of infection control practices among HCPs is 
essential in planning interventions in a health care setting. With this background, in the 
beginning of the interventional phase, a focus group discussion was carried out to assess the 
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knowledge and attitude of HCPs on infection control and hand hygiene practices. Thematic 
analysis came out with two major themes: Challenges with practice of IC and Interventions 
to improve. In challenges, the major sub category emerged was job related, heavy work load 
and emergency situations.[Table23]This is similar to other studies conducted in developing 
countries.
106,107,108 
 
 In interventions to improve the IC practices, availability of hand hygiene product at 
the point of care was suggested by many participants. As noted by other studies 
109,110
 
providing point of care hand hygiene products facilitates integration of hand hygiene in to 
the natural workflow patterns of HCPs and can contribute to HHC.  
 
 In answering to the question relating to the adequacy of practice of infection control 
by other staff members, only 63% of participants endorsed that all are adequately practicing 
infection control. 37% of participants reported that the infection control practice by other 
members was not adequate.Only 44% of participants were aware about the major infection 
control related problem of their work place. 
 
 Major barriers to Infection control, recognized in this study related lack of 
administrative support leading to inconsistent and inadequate supply of alcoholic hand 
hygiene products. Under staffing and overcrowding of patients causing increased work load 
to nursing staff was another major barrier.Administrative support is critical and it plays a 
pivotal role in effective implementation of infection control practices. Similarly a 
qualitative study by Anna K, concludes that, institutional support for infection control and 
prioritizing resources to recruit and retain trained, experienced nursing staff are critical to 
the effective implementation of infection control practices.
111 
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 The  outcome analysis of post interventional KAP questionnaire study showed T test 
value for knowledge to attitude, knowledge to practice and attitude to practice is 2.04, 
which was statistically significant (p value <0.001). [Table24]This implies that there is a 
significant conversion of knowledge to attitude and attitude to practice. HHC improved and 
trend analysis of CAUTI rate were reduced significantly.Even after this, the other IC 
indicators, like infection rate of respiratory samples and blood stream infection, MDRO 
rate, ESBL and Carbapenemase rate between pre and post interventional phases were not 
significantly reduced. This reflects the lack of organized infection control programs with a 
well-trained infection control team and an institutional climate that prioritizes infection 
control in the public sector hospital. 
 
 Two other similar interventional studies conducted from India also reports on the 
role of person and organizational level factors in improving the implementation of infection 
control and prevention measures.
112,113
 Furthermore, a recent international survey of 
infection prevention practices in thirty countries concludes that limited trained staff, 
inadequate infrastructure, and supplies were major barriers in preventing MDRO 
transmission.
114
Also following infection control practices and HHC involves, emotional 
sensitization and cultural transformation than acquiring knowledge and attitude. 
Behavioural change takes time to emerge.Infection control measures have to be given 
priority with recruitment of more personnel and with more budgetary allocation. 
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SUMMARY 
 
Setting: 
 Intensive Medical Care Unit (22 beds) of adult wards in a tertiary care hospital. 
 
Study design:  
 Prospective interventional  
 
Population characteristics:  
 Both male and female adult patients‟ age ranging from 12 to 86 years consecutive 
IMCU admissions during the study period. Doctors and other HCPs serving in the IMCU. 
 
Major infection control interventions during the study: 
 Focus Group Discussion, Training and education of HCPs on hand hygiene and 
infection control practices, Bundle approach was introduced for CAUTI prevention, 
maintaining charts in the form of monitoring tools on CAUTI and MDROs isolated from 
patients‟ clinical samples, and Providing Information Education Charts (IEC), ready 
reckoner materials at work place. 
 
 A total of 359 patients in the pre intervention and 353 patients in the post intervention 
phase were included in the study. 
 There was no significant variation in the male:female ratio.(1.01:1) 
 Various clinical samples with suspected infection, a total of 439 specimen in the pre 
intervention and 441 specimen in the post intervention were collected and subjected to 
culture in the study period. 
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 The most common isolates were gram negative pathogens. There was no significant 
difference between infection rate between base line and the post interventional phases.  
p =0.218. 
 In catheterised patient with clinically suspected CAUTI, 168 urine specimen in the pre 
intervention phase and 130 urine specimen in the post intervention phase were collected 
and subjected to culture. 
 The rate of development of CAUTI was higher as the duration of catheterization 
increased. p value 0.033946, Chi square value 6.766. 
 CAUTI rate calculated at the end of the pre and post intervention phase 22 and 21 per 
1000 catheter days respectively. 
 The mean duration of catheterisation was 11 days and 8.7 days in the pre and post 
intervention phases respectively. 
 Trend analysis of CAUTI rate was done by comparing 4 data points‟ showed significant 
reduction in infection rate. p= 0.012 
 In this study, maximum number of MDR pathogens were isolated from Tracheal 
aspirate specimen. K.pneumoniae (33%) was the most common MDR pathogen 
followed by Acinetobacter spp. (25%) and Pseudomonas spp. (20%). 
 ESBL rate was 78% and 70% in the pre and post intervention phases respectively. 
 There was no significant difference in the carbapenemase production (p= 0.667) in both 
the phases of the study. 
 After the intervention, there was a vast improvement in the HHC (p=0.007) and CAUTI 
rate was reduced significantly.  
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 Even after this the other IC indicators, like infection rate of respiratory samples and 
blood stream infection, MDRO rate, ESBL and carbapenemase rate between pre and 
post interventional phases were not significantly reduced.  
 This reflects the lack of organized infection control programs with a well-developed 
infection control team and an institutional climate that prioritizes infection control in the 
public sector hospital 
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CONCLUSION 
 HCAI is a major threat to the safety of patient care and it is a growing problem all over 
the world especially public sector hospital in a developing country. 
 In an IMCU setting, the urinary tract of catheterized patients is highly susceptible to 
infection by MDR pathogens.  
 HCAI associated with varied microbiological etiology and 39-46% of them was 
MDROs. 
 As the rate of development of CAUTI is significantly associated with the duration of 
catheterization emphasis should be made on reducing the duration of catheterization.  
 Intervention by training and education of HCP in infection control and HH significantly 
increased HHC. 
 Introduction of Bundle concepts in the prevention of CAUTI was very much beneficial 
with decrease in mean duration of catheterization by 2.3 days and CAUTI rate was 
significantly reduced in the post intervention phase. 
 Practising the IC methods such as HH and CAUTI bundle approach ultimately leads to 
cost effective patient care and patient safety. 
 MDRO rate and infection rate of Blood, tracheal aspirate, sputum and sterile fluid 
specimen were not significantly decreased. 
 CAUTI prevention bundle approach was successful as it was specific and focused. 
 Problems associated with infection prevention and control in a public sector hospital is 
multifactorial involving infrastructure, environmental and personnel. Comprehensive 
infection control intervention should not only involve training and education but should 
address all these factors. 
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 Major barriers to Infection control, recognized in this study related to lack of 
administrative support leading to inconsistent and inadequate supply of alcoholic hand 
hygiene products and under staffing and high bed occupancy of patients. 
 Understanding the perspectives of infection control practices among HCPs is essential 
in planning interventions in a health care setting. 
 Epidemiological Surveillance of HCAI is essential to understand the nature and extent 
of problem also it supports the clinicians in treating infections and helps in planning the 
prevention strategies to ensure a quality health care in any hospital. 
 Administrative support is critical and it plays a pivotal role in effective implementation 
of infection control practices. 
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RECOMMENDATIONS 
 
 The prevention, control and treatment of HCAI  is a concern of all health care 
professionals working in a hospital including microbiologists, clinical specialists from 
various disciplines of medicine and surgery, medical and nursing administrators. 
 By this structured intervention study, involving assessment, education and surveillance 
as components, HCAI rate was monitored.   
 The risk factors and local determinants for acquiring HCAIs were revealed and the 
outcome will be extremely useful.   
 Also such study unveils the challenges in implementation of infection control program 
in a resource constraint setting. 
 This study recommends the surveillance of HCAI which is very important to understand 
the nature and extend of problem which helps in planning the prevention strategies to 
ensure a quality health care in any hospital. 
 Thus it becomes important to undertake such studies at Institutional level and to share 
the knowledge, experience and quality improvement and research findings.  
 
LIMITATIONS 
 The study analyzed the effectiveness of IC practices using only three indicators. Many 
factors should be involved for improving IC in IMCU, as it is very difficult and 
complicated to improve IC. 
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Annexure (i) 
 
PATIENT CONSENT FORM & INFORMATION SHEET 
 
TITLE OF THE STUDY: “A study on assessment of challenges and effectiveness of 
infection control measures in a tertiary care hospital using specific infection control 
indicators.” 
Name :        Date  : 
Age :        OP No  :  
Sex :        Project Patient No : 
 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has been 
read to me). I was free to ask any questions and they have been answered. I hereby give my 
consent to be included as a participant in “A study on assessment of challenges and 
effectiveness of Infection control measures in a tertiary care hospital using specific 
infection control indicators.” 
I have read and understood this consent form and the information provided to me. 
1. I have had the consent document explained to me. 
2. I have been explained about my rights and responsibilities and about the nature of the 
study by the investigator.  
3. I have been advised about the risks associated with my participation in this study. 
4. I agree to cooperate with the investigator and I will inform her immediately if I suffer 
unusual symptoms. 
5. I have not participated in any research study within the past ________ month(s). 
6. I am aware of the fact that I can opt out of the study at any time without having to give 
my reason and this will not affect my future treatment in this hospital. 
7. I am also aware that the investigator may terminate my participation in the study at any 
time, for any reason, without any consent. 
8. I hereby give permission to the investigators to release the information obtained from me 
as result of participation in this study to the sponsors, regulatory authorities, Govt. 
agencies, and IEC. I understand that they are publicly presented. 
9. I have understood that my identity will be kept confidential if my data are publicly 
presented. 
10. I have had my questions answered to my satisfaction. 
11. I have decided to be in the research study. 
I am aware that if I have any question during this study, I should contact the investigator. By 
signing this consent form I attest that the information given in this document has been clearly 
explained to me and understood by me, I will be given a copy of this consent document. 
  
  
For participants: 
 
Name and signature / thumb impression of the participant (or legal representative if 
participant incompetent/for age 10-17 yrs-Name& signature of the parent/guardian.) 
 
Name ___________________________________ Signature_________________________  
Date________________ 
 
 
Name and Signature of impartial witness (required for illiterate patients): 
Name ___________________________________ Signature_________________________  
Date________________ 
 
 
Address and contact number of the impartial witness: 
Name and Signature of the investigator or his representative obtaining consent: 
Name ___________________________________ Signature_________________________  
Date_______________ 
  
Patient Information Sheet in Regional Language (Tamil) 
  
 Annexure (ii) 
 
PROFORMA 
 
Date  __ __ __ __ __ __ 
Patient  Name : __________________________  Age /Sex :           M / F  I.P.No:--------- 
 
Admitted on - ----- Unit / Ward : ------- / ---------  
 
 
Discharged  on No of Days of Hospital stay : 
 
Transfers if any : From :                                   To: 
Diagnosis : Provisional -----------------------------  
     Final --------------- 
Tt outcome  : 1.Discharged                   2.Expired               3. DAMA 
Risk factors  DM         HT            CKD        CLD          
Presenting complaints 
Duration of illness 
Previous history of similar illness or treatment 
Personal history 
Family History 
Clinical Examination- General Examination 
Systemic Examination 
Details of urinary catheterization   Indication: 
Functional status:                                           Conscious/ Unconscious: 
Date of insertion of urinary Catheter:           Date of removal of urinary Catheter: 
Date of Development of CAUTI: 
Daily monitoring for signs of inflammation 
E – elevated   N – normal  P –present 
  
        
        
  
Date              
Temperature              
X-ray              
IA line             
IV line             
Urinary catheter              
 
Investigations: Blood routine, urine routine and culture report 
 
Treatment:   Antibiotics                                                         Signed By: 
 
  
Annexure (iii) 
 
FACILITATION GUIDE FOR FOCUS GROUP DISCUSSION AMONG  
HEALTH CARE PROVIDERS  
Domains Universal precautions (UP) including use 
of PPE & vaccination 
Guidance for facilitator 
Knowledge What is Universal precaution (UP) in 
health care setting? 
The facilitator needs to explore the 
opinion of each and every 
participant. 
 Who should follow UP? Keep it opens ended and explore 
whether they are able to list out all 
cadres of hospital staff. 
 Why should HCP follow UP? Keep it open ended and explore 
whether they are able to list out the 
possible risk of acquiring 
infections. 
 When should HCP follow UP? Keep it open ended and explore 
whether they are able to list out the 
time when staff need to follow UP 
(In terms of 
emergency/ICU/OT/IMCU/Spl 
patient/etc). 
 How should HCP follow UP? Keep it open ended and explore 
whether they are able to list out the 
techniques of UP. 
 What else need to be done by HCP to 
protect themselves from acquiring 
infection? 
Assess whether the participants are 
able to discuss about vaccines and 
PPE. 
 What are the vaccines mandatory for 
HCP &What is the regimen for 
administration? 
Explore about HBV, & Typhoid 
vaccines for HCP & food handlers  
 How much does it cost for getting a 
complete course of vaccines? 
 
Explore whether the participant is 
aware about the total cost involved 
in getting a full course of vaccine 
Attitude Do you think whether it is essential for 
health care providers to follow UP? 
Explore the common opinion about 
the topic 
 Do you think it is a costly affair to 
follow UP 
Explore the opinion on whether the 
participants feel it costly to follow 
UP in all settings (from IMCU to 
OPD) & ( From Infectious diseases 
to non infectious cases) 
 Do you think it is a time consuming 
affair to follow UP? 
Explore the opinion on whether the 
participants feel it time consuming 
to follow UP in all settings (from 
IMCU to OPD) & ( From Infectious 
diseases to non infectious cases) 
Practices Do the HCP team in your ward/ 
department follow UP? 
Explore the current practices of 
other health workers  (last 3 
months) in their ward/ theatre, etc 
 Do you follow UP? Explore the current practices of the 
participant ( last 3 months) in their 
ward/ theatre, etc 
If yes- whether it is followed at all 
times & all sites? 
If no - where & when it is not 
followed? 
 
 
Hospital Infection Control including 
Hand hygiene 
Guidance for facilitator 
Knowledge What is Health care associated infection 
(HCAI)? 
Keep it open ended and explore 
every ones opinion 
 What are the ways and means of 
preventing HCAI? 
Explore whether able to list out the 
methods. 
 Who are getting benefits of good HIC 
procedure? 
Explore whether able to list 
everyone 
 Are you aware of WHO recommended 5 
moments of hand hygiene? 
Keep it open ended and explore 
every ones opinion 
 What are surveillance data you collect, 
to assess the HAI? 
Explore the current practices 
 What are the pre-planned nursing care 
plan available at IMCU? 
Are everyone working in IMCU aware 
about that? How do you ensure? 
Keep it open ended and explore 
every ones opinion & Explore the 
current practices 
Attitude Who is responsible for HIC? Keep it open ended and explore 
every ones opinion 
 Do you feel is it necessary to collect 
ward surveillance data on HCAI? 
Explore the common opinion about 
the topic 
  What do you think are the major 
infection problems in your facility? 
 
Explore the common opinion about 
the topic. 
Practices How often you wash your hands? 
Like every 10 minutes,30 minutes etc 
Explore the current practices of 
HCPs  ( last 3 months) in their 
ward/ theatre, etc 
 How many times on an average you do 
hand hygiene in your shift duty of 8 
hours? 
Explore the current practices of 
HCPs  ( last 3 months) in their 
ward/ theatre, etc 
 What is the average duration of hand 
washing? 
Like 10 sec/20sec/40sec 
Explore the current practices of 
HCPs  ( last 3 months) in their 
ward/ theatre, etc 
 How do you ensure that every HCP 
posted in IMCU is aware of IC 
procedures? 
Explore the current practices 
 
 
Barriers in 
implementation 
What are the common barriers stated 
by your HCP team for implementing 
UP or to hand hygiene compliance/ 
IC practices 
 
Explore the common barriers 
which they face as a team in 
implementation of UP. 
Explore the common barriers like 
lack of knowledge/ awareness 
-inadequate supply of hand 
rub/PPE. 
-heavy work load. 
-lack of accessible place to wash 
hand 
 
 What are the common barriers you 
feel for implementing UP in your 
work place 
Explore the common barriers 
which they face as individuals in 
implementation of UP. 
 How does address these barriers? 
Suggestion 
Ask about the suggestions they 
would provide for Hospital 
administrators, department heads, 
Doctors, trainees, Nursing & other 
paramedical faculty, Sanitary 
workers 
 If the barriers are removed will it be 
easy for them to practice UP?  
Explore if participants say “yes”– 
How frequently would they need 
support( training, monitoring/ 
mentoring by superiors) 
If they say“no” – What would still 
prevent them from following it 
 
  
Annexure (iv) 
 
MONITORING OF DIVICES 
 
NAME :                              AGE /SEX  :                        IP NO: DOA: 
 
DATE 
Temperature 
Urinary 
Catheter 
Venflon 
Ryle’s 
Tube 
Ventilator ET/TT Central line Others 
N I Day Care Day Care Day Day Care Day Care Day Care  
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
 
N-normal, I- increased, ET – endotracheal tube, TT – Tracheal tube 
  
Annexure (v) 
INFORMATION EDUCATION COMMUNICATION –  POSTERS 
 
 
  
  
   
   
   
  
Annexure (vi) 
 
URINARY CATHETER CARE BUNDLE - INSERTION BUNDLE  
-Insert only for specific reasons 
• Urinary output in critically ill 
• Bladder outlet obstruction or neurogenic bladder dysfunction 
• prevent contamination of sacral wounds. 
•Terminal care  
- Competent HCP to insert 
- Aseptic technique 
- Closed system with bag below bladder 
 
URINARY CATHETER – MAINTENANCE BUNDLE  
OBSERVATION                                                                           ELEMENTS 
Date/Days Hand 
Hygiene 
Catheter 
Hygiene 
Aseptic 
Sampling 
Drainage 
bag position 
Catheter 
Manipulation 
Catheter 
Needed 
1       
2       
3       
4       
5       
6       
7       
8       
9       
10       
11       
12       
13       
14       
15       
 
  
Annexure (vii) 
  
KAP QUESTIONNAIRE 
 
Infection Control Training – IMCU.  
 
Do you know the order of donning of PPE? 
           
1. How to perform FIT CHECK for a respirator? 
          
2. What is the Sequence for Removing PPE? 
 
3. Where to remove the PPE? 
 
 
4. While practicing standard work precautions the HCW should assume that an 
infectious agent could be present in the patient’s blood or body fluids, including all 
secretions and excretions except ------------ and -------------- 
5. What is Health care associated infection? 
 
7. What are the types of Health care associated infections (HAI)? 
 
8. What are the Denominator data to collect for device-associated HAI incidence density 
rate calculation? 
 
 
9. What is an outbreak? 
 
10. What is the commonest HAI? 
 
 
11. What is Daily Defined Dose (DDD)? 
 
12. What is a multi drug resistance organisms (MDROs)? 
 
 
13. Name few MDROs 
 
14. To identify MRSA carriers which body sites should be tested?  
 
 
15. What is the quantity of biomedical waste generated per bed per day? 
16. As per the Bio-Medical Waste Management Rules 2016, BMW is classified under 
how many categories? 
 
17. What is the Legal Implication of any violation of BMWM rules? 
 
 
18. Name few indications for urinary catheterisation: 
 
19.  How will you collect urinary sample in a catheterized patient? 
 
 
20. Name any 2 steps in ongoing catheter care: 
 
21. Why the urinary catheter   should be properly secured after insertion? 
 
22. What are the situations where you can use unsterile gloves? 
 
 
23. What is the recommended disinfectant for environmental cleaning? 
 
24. How will you store the thermometer? 
 
 
25. How will you clean blood spill? 
 
26. What are Critical, Semi-critical, Non-critical instruments? 
 
 
27. What is the shelf life and contact time for Glutaraldehyde? 
 
 
28.  How will you handle Mucosal exposure e.g. splash into eyes? 
 
 
29. What is the method of Preparation of skin preferred before attempted insertions of 
central intravenous catheters, catheters requiring cutdowns, and arterial catheters? 
 
 
30. What is the recommendation for the Replacement of Peripheral IV Catheters: 
 
 
31. What is the recommendation for the Replacement of central IV catheters: 
 
32. How will you remove Catheter line when suspecting central line Infection? 
 
 
33. What is the water used for rinsing the reusable semicritical reapiratory equipment and 
devices? 
 
 
34. How often you need to change heat and moisture exchanging filter (HMEF)? 
 
 
35. What are the few steps need to be followed while doing suctioning of endotracheal / 
tracheostomy tube? 
 
36. How you prevent aspiration associated with enteral feeding? 
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Abstract 
Background: Health system today is very dynamic and patients admitted in intensive medical care unit (IMCU) are under the 
greater risk of morbidity and mortality due to health care-associated infections (HAIs). Rates of HAIs and bacterial resistance in 
developing countries are 3 to 5 times higher than international standards. Many studies reveal that, Organized infection control 
(IC) programs have been successful in reducing the HAI with subsequent improvement in the hand hygiene compliance. 
Understanding the perspectives of infection control practices among health care workers (HCWs) is essential in planning 
interventions in a health care setting. On this background this qualitative study was carried out. 
Aims : To explore perceptions of HCWs of intensive care unit, on infection control and hand hygiene using focus group 
discussions (FGDs) in a tertiary care hospital in India. 
Methods and Materials: The prototype facilitation guide for focus group discussion was prepared. Six discussions were 
conducted in English and Tamil, were recorded, transcribed verbatim, translated into English and analysed using content analysis. 
Discussions ranged in length from 30-45 minutes. 
Results and conclusion: On thematic analysis two major themes emerged. They are 1.Challenges with practice of infection 
control and2. Interventions to improve. The participants acknowledged the value of Standard Precautions and infection control 
practices as a means for reducing HAI but perceived practical problems with implementation. 
Awareness and preparedness were satisfactory whereas clarity on basic concepts and current updates appeared lacking. 
Key words: Focus group discussions, hand hygiene, health care-associated infections, Intensive care unit, Infection control, 
qualitative study, standard precautions. 
 
Introduction 
Health system today is very dynamic and patients 
admitted in intensive medical care unit (IMCU) often 
requires a persistent intensified therapy. More serious 
underlying illnesses makes the patients susceptible to 
infections.[1] Also increased use of invasive 
procedures in modern, sophisticated medicine creates 
new sources of risk for infection.[2] 
So, health care-associated infections (HAIs) with 
greater risk of morbidity and mortality are common 
in IMCU patients.[3] 
Many studies reveal that, rates of HAIs and bacterial 
resistance in developing countries are 3 to 5 times 
higher than international standards. [4, 5] 
Infections today requires highly individualized 
treatment, sometimes with multiple therapies, based 
on the antibiotic susceptibility pattern of the infecting 
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organisms, condition of the patient and which organ 
system is affected. The emerging multi drug resistant 
organism further complicates the picture causing 
prolonged antibiotic therapy and prolonged hospital 
stay. The economic, clinical, and social expenses to 
patients and hospitals are overwhelming.[6] 
Since its recognition by Semmelweis in the 18th 
century[7] hand hygiene is judged the most important 
measure and it is the corner stone for prevention of 
microbial transmission during patient care. However, 
hand hygiene is in irregular practice in resource 
constraint settings, historically reported at rates of 
less than 20%, [8-10] -40%. [11, 12] 
Organized infection control (IC) programs have been 
successful in reducing the HAI with subsequent 
improvement in the hand hygiene compliance to 
50%. [13] 
Hence to limit the incidence of IMCU-acquired 
infections aggressive infection control measures must 
be implemented and enforced.Understanding the 
perspectives of infection control practices among 
health care workers (HCWs) is essential in planning 
interventions in a health care setting. On this 
background this qualitative study was carried out to 
assess the knowledge and attitude of HCWs on 
infection control and hand hygiene practices. 
Objectives  
- To understand the perspectives of HCWs working 
in IMCU, on infection control. 
-To assess the knowledge and attitude of infection 
control among HCWs. 
-To explore the problems and challenges involved 
with infection control practices. 
 
 
 
Methodology 
With the help of the practical guide for Good 
Questions proposed by Richard Kruegar and Mary 
Anne Casey [14] the prototype facilitation guide for 
focus group discussion (FGD) was prepared.The 
facilitation guide included the following topics: 
general awareness and knowledge about standard 
work precaution, infection prevention and hand 
hygiene, their attitudes regarding their own and 
others’ hand hygiene practice at the site, and their 
ideas on challenges involved with infection control 
practices and preparedness for improving infection 
prevention efforts. Pilot testing, refinement, and 
validation of the survey questions were conducted. 
This study was approved by the Institutional ethics 
committee. Participants were explained about the 
purpose of the study and ensured that their responses 
will be kept confidential. Written consent to 
participation was obtained from each participant. 
Discussions ranged in length from 30-45 minutes. 
The discussions were conducted in English and 
Tamil, recorded on tape, transcribed, and, translated 
into English. Facilitator participated only to keep the 
discussion active and focused. On the day of FGD, 
the facilitator used pre-determined question and 
established permissive environment. An assistant 
moderator handled logistics, taken careful notes and 
monitored recording equipment. After the welcome 
and the introduction the participants were high 
lightened about the agenda of the discussion and the 
guidelines of the FGD were told. The facilitator 
guided the discussion with the help of the facilitation 
guide. 
Six focus group discussions were held with 12 nurses 
and 10 emergency care technicians. Transcripts were 
analyzed by thematic content. 
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Results 
Table: 1 Thematic content of focus group discussion 
S.no Major Theme Sub Category 
1 Challenges with practice of infection control *Heavy work load  
*Knowledge of core concepts 
* Complacency 
2 Interventions to improve *Need for training 
* Designated infection control personnel 
* Monitoring 
 
Thematic analysis came out with two major themes 1. 
Challenges with practice of IC and  
2. Interventions to improve. (Table 1) 
In challenges, the major sub category emerged was 
job related, work load and emergency situations. It 
was evident by the following statements. 
“In pressing situations, I rush to attend the patient 
than to pause for the hand hygiene.” 
“Yes. It is good to do surveillance of health care 
associated infections. But we are afraid to commit 
this because it will bring more work to us.” 
In addition, essential knowledge of core concepts of 
infection prevention practices seemed lacking and 
was revealed in terms of beliefs and adaptation to the 
setting.  
Most of the participants felt that following the 
standard work precaution was a costly affair. One 
staff nurse stated that, “I do not feel my hands are 
dirty often to do hand rub.” 
Complacence due to prolonged work experience was 
another challenge. Many admitted that, “We all do 
correctly by our experience…..” 
“We were told to document the number of times the 
catheter changed. It was hard to follow. We changed 
the catheter correctly but not documenting.” 
In barriers to practice IC, people trafficking in IMCU 
were another challenge. The following statements 
revealed this. 
“The lab technician and dialysis technician need to be 
told and trained on IC practices” 
“Patient attendees’ are a constant problem to us. 
Sometimes we may also depend on them for patient 
care.” 
The second major theme emerged was on 
interventions to improve the IC practices. 
All appreciated the administrator for the adequate 
availability of personal protective equipments. They 
also insisted on point of care availability of hand rub. 
The importance of the designated IC nurse and 
monitoring was insisted by all. 
The importance of training to foster behavior change 
emerged throughout the discussions. Need for 
training and updating on current guidelines was felt 
and voiced by everyone. 
“Whatever we are doing is by our basic nursing 
knowledge. We need to have regular training on IC 
guidelines.” 
“The interns are not aware and updated on IC 
practices” 
“We are willing to get trained and practice…” 
 All of the participants expressed their willingness to 
change and their preparedness to adapt HH practices. 
Their openness to accept the change and to evolve 
out of their perceived preconception was evident by 
the statement that, “This discussion made us think…” 
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Discussion 
To improve the infection control practices of any 
setting the first step is to understand the challenges to 
establish the one. So the perspectives of health care 
workers will be vital in developing interventions 
most appropriate to the local context. 
In this study, the participants acknowledged the value 
of Standard Precautions as a means for providing 
protection against occupational exposure to 
microorganisms and cross contamination. To practice 
the IC the major challenge observed was job related 
factors like heavy work load and emergency 
situations. Many participants described an emergency 
situation as a major obstacle in following 
precautions. This is similar to other studies. [15, 16] 
Also in a qualitative study conducted at Vietnam the 
HCWs expressed frustration with high workload.[17] 
Forgetful-ness and lack of time was the reason for 
poor adherence of infection control practices in other 
studies. [18, 19] 
When nurses gain enough experience, they are very 
confident about their capabilities. Therefore, they lull 
themselves to skip certain steps in a guideline, in a 
study as argued by a nurse with considerable clinical 
experience: "...the more capable I feel, the less 
preventive measures I may take."[15] 
In interventions to improve the IC practices, 
availability of hand hygiene product at the point of 
care was suggested by many. As noted by other 
studies [20, 21] providing point of care hand hygiene 
products facilitates integration of hand hygiene in to 
the natural workflow patterns of health care providers 
and can contribute to higher hand hygiene 
compliance.  
Lack of knowledge, training and education was one 
of the challenges with the practice of IC. As reported 
by a study, education had a positive impact on 
retention of knowledge, attitudes and practices in all 
the categories of staff.[22] Similarly, in a study by 
Naggar RA, emphasis was given for educational and 
motivational intervention on infection control to 
target nursing students. [23] As per a report by WHO, 
staff education is a key element and basic principles 
of IC should be included in curricula of doctors, 
nurses and other health care professions.[24] So there 
is a need to develop a system of continuous education 
for all the categories of staff. 
Conclusion 
This study provides an insight into what the hospital 
staff perceives about IC and their current practices, 
how do they act and react, what are their training and 
other needs. Awareness and preparedness were 
satisfactory whereas clarity on basic concepts, current 
updates, involvement, and performance appeared 
lacking which necessitates the system change. The 
results can be used by nurses, administrators, 
policymakers, and nurse educators as a means of 
strengthening the IC practices among nursing 
personnel. 
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